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Abstract 
Coagulase-negative staphylococci (CNS) are the most common bacteria isolated from 
subclinical mastitis in several countries and are also a frequent cause of clinical mastitis. 
The prevalence of CNS mastitis is higher in primiparous cows and the most common 
species isolated are S. chromogenes, S. epidermidis, S. xylosus and S. simulans. The 
distribution of species differs among countries and herds. Half of CNS intramammary 
infections (IMI) persist in the udder for long periods and although cure rates after 
antimicrobial therapy are usually high, antimicrobial resistance among CNS can be a 
problem. The inflammation in the infected quarter is usually mild, and treatment at drying-
off is recommended rather than during lactation. Some risk factors for CNS mastitis have 
been recognised in epidemiological studies that should be taken into account in herd 
health plans. The pathogenesis of CNS intramammary infection is poorly understood. 
 
This dissertation focuses on host response to S. chromogenes, S. epidermidis and S. 
simulans in bovine experimental intramammary infection. A model for mild 
experimentally induced mastitis was developed with S. chromogenes (study I). This 
infection model revealed a diurnal rhythm in milk amyloid A (MAA) concentrations, the 
content of which was higher in the mornings despite dilution in a greater volume of milk. 
 
The dose of bacteria used for inoculation in study II was higher in order to induce 
clinical mastitis. The innate immune response of S. epidermidis and S. simulans was 
compared in eight cows using a crossover design. All cows became infected and showed 
mild to moderate clinical signs of mastitis. S. simulans causes a slightly stronger innate 
immune response than S. epidermidis, with significantly higher concentrations of IL-1? 
and IL-8. The spontaneous elimination rate of the 16 infections was 31%, with no 
difference between species. Infections triggered a local cytokine response in the 
experimental udder quarters, but cytokines were not detected in the uninfected control 
quarters or in systemic circulation. The IL-8 response could be divided into early, delayed, 
or combined types of response. Neither the CNS species nor persistence of infection were 
associated with the type of IL-8 response. No significant differences were recorded 
between spontaneously eliminated and persistent infections, although the response was 
stronger with spontaneously eliminated infections, except with tumor necrosis factor ? 
(TNF-?), which remained elevated in persistent infections. 
 
Lactoferrin (Lf) is a component of the humoral defence of the host and is present at 
low concentrations in the milk. It is an iron-binding glycoprotein, which has bacteriostatic 
and bacteriosidic activity, as well as immunoregulatory functions. The concentration of Lf 
in milk is high during the dry period, and in colostrum and mastitic milk. The effect of an 
inherent, high concentration of lactoferrin in the milk in experimental CNS intramammary 
infection was studied in transgenic cows that expressed recombinant human Lf in their 
milk. Human Lf did not prevent S. chromogenes IMI, but the host response was milder in 
transgenic animals compared with normal cows and the infection was eliminated sooner.  
 
  
 
 
 
Biofilm and slime formation assist bacteria in avoiding host immune defences and 
antimicrobial therapy. Biofilm has been suspected of affecting the severity or persistence 
of CNS mastitis. The phenotypic biofilm formation and slime producing ability of CNS 
isolates from bovine mastitis was investigated in vitro. Genes encoding the adhesion 
proteins MSCRAMM (microbial surface components recognizing adhesive matrix 
molecules) and biofilm-associated proteins (bap) were detected. One-third of mastitis 
isolates produced biofilm. The Kappa test value, measuring the agreement between two 
phenotypic biofilm tests, differed among CNS species. Slime production was less frequent 
for isolates of the common mastitis causing species S. chromogenes (0.2% of isolates 
produced slime) and S. simulans (3.5%) compared with S. epidermidis (40%). No 
association was found between the phenotypic ability to form biofilm and the persistence 
of IMI or severity of mastitis. Slime production was associated with persistent infections, 
but  as  a  rare  event  its  clinical  relevance  remains  uncertain.  The  eno gene, encoding 
laminin-binding protein, was most frequently detected among the mastitis isolates, 75% of 
which have this gene. Only a few other MSCRAMM genes were detected.  
 
The results of this dissertation indicate that experimental infection using three CNS 
species, S. chromogenes, S. epidermidis and S. simulans, triggers a systemic and local 
immune response of the cow. Differences among species were found in host response, and 
in biofilm and slime production of CNS isolated in mastitis. A high lactoferrin 
concentration in milk contributed to milder inflammation and more rapid elimination of 
infection from the quarters, but did not protect the mammary gland from infection. The 
common CNS species isolated in mastitis produce less biofilm and slime than isolates 
from other sources, except S. epidermidis. Biofilm or slime producing ability has no effect 
on the clinical severity of mastitis or on the persistence of CNS infection. This dissertation 
provides knowledge on the pathogenesis of the most important CNS species that can be 
useful in developing control strategies for CNS mastitis. 
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 Introduction 
 
Mastitis  is  the  most  economically  important  disease  of  dairy  cows (Halasa  et  al.,  2007).  
Despite mastitis having been researched for decades, the problem it represents has not 
been solved and incidence of mastitis still remains high in most countries. Development 
and structural changes in the dairy industry have also contributed to udder health. Herd 
management, in addition to changes in barn design, have changed considerably over recent 
decades and impacted aspects of udder health. In Finland, traditional, small stanchion 
barns have been replaced with larger free stalls, which have provided cows with more 
comfort but on the other hand may have new problems for instance in keeping cows clean 
or in maintaining milking order. Moreover, breeding for higher milk production has 
affected the capacity of the immune system of dairy cows to combat infections, and the 
associated bacteria have adapted to changes in their hosts and environments. Consequently 
although the prevalence of mastitis caused by major pathogens (Staphylococcus aureus, 
Streptococcus uberis, Escherichia coli etc.) has decreased in many well-managed dairy 
herds, the prevalence of intramammary infections caused by coagulase-negative 
staphylococci (CNS) has increased.  
 
Mastitis negatively affects the quality of milk, milk production, farm economics and 
animal welfare. Calculations of economic losses resulting from mastitis vary among 
countries. In Finland, the estimation is 220 €/cow per herd/year (http://www.smts.fi 
/jul2010/esite2010/089.pdf). The overall safety and quality of bulk milk in Finland is high, 
the geometric mean of the raw milk samples in 2010 in Finland being 134 000 cells/ml 
and the premium category of the milk includes 94% of all raw milk produced (http: 
//www.maitohygienialiitto.fi/laatu_jak_luokkiin_03.html). This premium category 
requires the geometric mean of the bulk milk somatic cell count (SCC) samples to be 
below 250 000 cells/ml during the recent 3 months and the bacterial count to be below 
50 000 colony forming units (CFU)/ml during the last 2 months. At the farm level this 
excellent result demands strict monitoring of udder health and milk quality, close attention 
of the farmers and in many cases greater costs due to treatments, culling of mastitic cows, 
and discarded milk.  
 
CNS are the most common cause of subclinical mastitis in many countries (Bradley et 
al., 2007; Koivula et al., 2007; Piepers et al., 2007; Sampimon et al., 2009). High 
prevalences of clinical mastitis have also been reported in some countries (Koivula et al., 
2007; Olde Riekerink et al., 2008; Tenhagen et al., 2009). The prevalence of CNS mastitis 
is highest in heifers after the first calving and the most common species of bacteria 
isolated are S. chromogenes, S. epidermidis, S. xylosus and S. simulans. In many studies, 
cows with CNS intramammary infections (IMI) have been particularly high-yielding. It is 
not known if high yielding cows are more sensitive to CNS IMIs or whether their higher 
milk production results from the preventive effect of CNS infections, which reduces 
clinical mastitis caused by the major pathogens. 
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Control of mastitis is based on knowledge of the epidemiology, ecology, and 
pathogenesis of mastitis-causing bacteria. Some epidemiological studies on risk factors for 
mastitis due to CNS have been published (Sampimon et al., 2009; Piepers et al., 2011). 
Pathogenesis of CNS bacteria in bovine mastitis is still largely unexplained and could 
differ from that for other species. Bacteriological studies have mainly been focused on S. 
epidermidis, an important opportunistic pathogen in human infections. 
 
This dissertation concerns the host response to S. chromogenes, S. epidermidis and S. 
simulans in bovine experimental IMI. The effect of high inherent lactoferrin (Lf) in milk 
on CNS host response was studied in vivo. Occurrence of biofilm and slime production for 
different  CNS  species  isolated  from  mastitis,  as  well  as  their  effects  on  CNS  IMI  were  
also studied in vitro. 
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Review of the literature  
1 Coagulase-negative staphylococci in bovine mastitis 
1.1 Genus Staphylococcus 
Staphylococcus spp. are medium-sized, spherical Gram-positive bacteria. Staphylococci 
are a part of the normal microbiota in animals, including humans. The genus 
Staphylococcus currently includes 50 separate species (http://www.ncbi.nlm.nih.gov/ 
Taxonomy/Browser/ wwwtax.cgi??mode=Info&id=1279), but with increasing accuracy of 
genotyping methods the number of species is growing. The most important pathogen in 
this genus is S. aureus. CNS are distinguished from coagulase-positive Staphylococcus 
species using a rabbit plasma coagulase-test. CNS are considered to be opportunistic 
pathogens (Irlinger, 2008), although they can cause serious infections, for instance, in 
humans (von Eiff et al., 2002).  In the routine diagnostics of mastitic milk CNS are not 
identified to the species level.  
 
In recent years, many studies have focused on accurate identification of different CNS 
species. It is now clear that phenotypical methods, which were developed for identifying 
important species isolated from humans, such as S. epidermidis, cannot satisfactorily 
differentiate CNS species isolated from other animals (Zadoks and Watts, 2009; Park et 
al., 2011a).  
 
Many different genotypic methods are used for species differentiation. Amplified 
fragment length polymorphism (ALFP) (Taponen et al., 2006), oligonucleotide (GTG)5-
fingerprinting (Braem et al., 2011), gas chromatography (Paradis et al., 2010b), ribotyping 
(Carretto et al., 2005), rboB sequence-based genotyping (Drancourt and Raoult, 2002), 
high resolution melt analysis of 16S rDNA sequences (Ajitkumar et al., 2010), gap PCR-
RFLP (Park et al., 2011a), tuf gene sequence-based genotyping (Capurro et al., 2009) and 
transfer RNA- intergenic spacer PCR (tRNA-PCR) combined with capillary 
electrophoresis (Supré et al., 2009) are promising or already useful tools for species 
identification if the background library for different strains of the various species is 
comprehensive. 
 
In addition to identification of species, the amount of CFUs in milk considered to 
represent a positive result of bacteriological culturing is also important. Finnish studies, 
among some others, have used 500 CFU of CNS/ml as the cut-off for a positive 
bacteriological diagnosis, i.e. the same figure as used for other mastitis-causing bacteria 
(Trinidad et al., 1990b; Pitkälä et al., 2004; Taponen et al., 2006). Definitions for a 
positive finding, however, have ranged from 100 CFU/ml (Bradley et al., 2007; Piepers et 
al., 2007) to 1000-5000 CFU/ml (Osterås et al., 2006; Gillespie et al., 2009; Perry et al., 
2010). According to Davidson (1992) and Dohoo (2011), the best sensitivity and 
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specificity with CNS cultures is achieved with a cut-off of 200 CFU/ml. According to 
these authors, use of a cut-off of over 500 CFU/ml decreased sensitivity by over 50%. 
Different interpretations may affect results from prevalence studies of CNS mastitis, or for 
example, assessing the impact of CNS IMIs on milk SCC and milk production, and 
distribution of different species isolated. 
1.2 Prevalence of CNS mastitis and intramammary infections 
CNS have become more important as mastitis-causing agents of cows during recent years 
and have become the most frequently isolated micro-organisms in bovine IMI in many 
countries (Pitkälä et al., 2004; Piepers et al., 2007). In the Finnish national mastitis survey, 
where all quarters of cows were sampled from a random sample of all dairy herds, 17% of 
all  quarter  milk  samples  were  CNS  positive  and  the  proportion  of  CNS  of  all  isolated  
pathogens was 50% (Pitkälä et al., 2004). In the Netherlands, 11% of all quarters and 32% 
of cows were CNS positive (Sampimon et al., 2009). A similar prevalence was reported in 
Belgium,  where  12.5%  of  the  quarters  and  41.1%  of  the  cows  were  infected  with  CNS  
(Piepers et al., 2007). The proportion of CNS is especially high in subclinical mastitis and 
CNS are also more commonly isolated in clinical mastitis. In England and Wales the 
prevalence of CNS mastitis was 8.1% in clinical mastitis and 14.9% in subclinical mastitis 
(Bradley et al., 2007). In Finnish routine mastitis sampling the prevalences were 17.6% 
and 23.5%, respectively (Koivula et al., 2007). Incidence rate of clinical CNS mastitis in 
Canada is 1.15 per 100 cow years, which is lower than that for three major mastitis 
pathogens (Olde Riekerink et al., 2008).  A total of 11% of samples from clinical mastitis 
were positive for CNS. In Sweden, prevalence of CNS in clinical mastitis was 6.2%, and 
an increasing trend was seen compared with a previous study (Ericsson Unnerstad et al., 
2008). 
 
Prevalence studies of CNS mastitis, including genotypic identification of species, are 
still rare. The most commonly isolated species have been S. chromogenes, S. epidermidis, 
S. haemolyticus, S. simulans and S. xylosus (Table 1) (Taponen et al., 2006; Taponen et 
al., 2007; van den Borne et al., 2010b; Persson Waller et al., 2011; Sampimon et al., 2011; 
Supré et al., 2011). Species distributions vary among countries and herds, but the reasons 
for this are not known.   
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Table 1 The most common CNS species (%) isolated in different studies, identified by 
genotypic methods. 
  
S. 
chromogenes S. cohnii 
S. 
epidermidis 
S. 
haemolyticus 
S. 
simulans 
S. 
xylosus 
Taponen et al., 
20061 
27.3  5.1 3 36.4  
Sampimon et al., 
20112 
35.9 2.9 13.5 5.3 5.3 8.8 
van den Borne et 
al., 20103 
53.8 1.3 7.5 18.8 0 3.8 
Persson-Waller 
et al., 20114 
24  22 14 18 4 
Supré et al., 
20115 
46.4 11.2 0.6 6.1 9.5 15.6 
Taponen et al., 
20076 
34.9 1.6 9.5 22.2 14.3 3.2 
 
1 99 cases of mastitis (clinical and subclinical) from 59 herds 
2 170 cases of mastitis (not specified) from 170 herds 
3 80 subclinical cases of mastitis 
4 56 clinical cases of mastitis from 55 herds and 98 subclinical cases of mastitis from 94 
herds 
5 IMIs in 3 herds  
6 IMIs in one herd 
 
The  CNS  IMI  can  exist  in  the  mammary  gland  in  unbred  and  prepartum  heifers  for  
several months before parturition (Trinidad et al., 1990b). CNS cause the most IMIs in 
heifers before parturition (Fox, 2009). The median prevalence of subclinical IMI caused 
by CNS (data compiled from many studies in a review article) in primiparous cows was 
31% before calving and 28% after calving (Fox, 2009). It is unclear if the same CNS 
genotypes persist in the mammary gland before the development of the udder and after 
parturition. Studies concerning the prepartum period were carried out mainly before 
introduction of the new genotypic methods for identification of CNS species.  
1.3 Bovine mastitis caused by CNS 
CNS mastitis is usually mildly clinical or subclinical (Taponen and Pyörälä, 2009). In 
subclinical mastitis, the cow has no systemic or local clinical (visible) signs and the 
appearance of milk is normal. An increased SCC or increased concentration of some other 
indicator of inflammation is detected in the milk using a diagnostic test. In clinical 
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mastitis, some clinical signs are present, either systemic, local or both, with changes in the 
milk appearance (International Dairy Federation, 1999). 
 
Intramammary  CNS  infection  can  be  found  in  a  quarter  with  a  normal  milk  SCC  
(<100 000 cells/ml) (Piepers et al., 2010), and SCC may fluctuate (Taponen et al., 2007). 
Infection  can  be  transient  and  be  eliminated  spontaneously  or  remain  persistently  in  the  
mammary gland (Chaffer et al., 1999; Taponen et al., 2007; Gillespie et al., 2009). It has 
been shown that half of CNS IMIs persist in the udder for long periods (Taponen et al., 
2006; Thorberg et al., 2009; Supré et al., 2011). In a Swedish study, infections caused by 
S. chromogenes, S. epidermidis and S. simulans were reported to persist in the quarter for 
longer times compared with other CNS species (Thorberg et al., 2009). In that study, 
phenotypic methods were used for species differentiation. The majority of IMIs due to S. 
chromogenes, S. epidermidis or S. simulans persisted (over a period of one month) and S. 
xylosus and S. haemolyticus caused transient infections (Thorberg et al., 2009). In another 
study from Belgium, only S. chromogenes was associated with persistent infections (Supré 
et al., 2011). 
 
Primiparous cows have significantly more CNS IMIs than multiparous cows 
(Sampimon et al., 2009). In Germany, the prevalence of clinical mastitis in primiparous 
cows was 27.4% and in multiparous cows 16.4% (Tenhagen et al., 2009). S. chromogenes 
was found more frequently in primiparous cows than in older cows and S. epidermidis 
more often in older cows. Regarding S. simulans infections, no differences were found 
between parities (Thorberg et al., 2009). 
 
Histological changes in CNS IMI have been investigated in udders from slaughtered 
mastitic cows. Inflammatory changes were not found with CNS IMI in four quarters out of 
99 studied (Benites et al., 2002). In other quarters the findings included different stages of 
acute or chronic inflammatory reactions. In this study no differences in the main 
histopathological results were found between infections caused by S. aureus (19 quarters) 
and CNS (Benites et al., 2002). In other studies, S. aureus infection caused more 
prominent pathological changes such as collapsing of the alveolae, necrotic areas and 
fibrosis in the affected quarters (Schalm et al., 1971), and interpretation of the study by 
Benites et al. (2002) should be made with caution. In another study on unbred heifers, 
CNS infection increased connective tissue stroma and leukocytosis in the quarter 
(Trinidad et al., 1990a).  
 
CNS are considered to be minor pathogens, and economic consequences of CNS IMIs 
to the dairy farm are not as clear as for major pathogens. Direct impacts of CNS mastitis 
on farm economics could be associated with an increased bulk milk SCC and with 
possible negative effects on milk production. Mastitis is, however, always an animal 
welfare issue (Leslie et al., 2010). 
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1.3.1 Somatic cell count 
CNS infections have a moderate effect on milk SCC. In a meta-analysis by Djabri et al. 
(2002) IMIs caused by CNS increased quarter milk SCC to 138 000 cells/ml (geometric 
mean). In the Finnish mastitis survey 18% of the quarters infected by CNS had an SCC of 
over 300 000 cells/ml (Pitkälä et al., 2004). It must be pointed out that these figures were 
quarter SCCs, which will be diluted by the low-SCC milk from the healthy quarters, and 
SCC of the composite milk could still be within normal limits. Uninfected cows, and those 
eliminating CNS infection rapidly after parturition, have a constantly lower milk SCC 
during the first lactation compared with cows with long-lasting CNS infections. 
Primiparous cows infected by CNS (n=168/1691) within the first month of lactation had a 
higher SCC throughout lactation compared with non-infected herd mates (Paradis et al., 
2010a). In that study, the bacteriological diagnosis was based on composite milk samples. 
In  a  Belgian  study  on  pathogen-specific  effects  of  IMI  in  early  lactation  (Piepers  et  al.,  
2010), primiparous cows infected by CNS (n=55/155) had a moderately increased SCC 
during lactation: geometric mean for SCC was 75 000 cells/ml in the CNS-infected cows 
and 53 000 cells/ml in the non-infected cows. Here the bacteriological diagnosis was 
based on two consecutive quarter milk samples after calving. In other study from Belgium, 
the geometric mean of quarter SCC with CNS IMI was 137 000 cells/ml (the 25th to 75th 
percentiles 74 000-298 000 cells/ml) (Supré et al., 2011). 
 
Recent studies focus on looking for differences between CNS species. Consequently it 
is difficult to have sample sizes large enough, except for the main CNS species. In a pilot 
study, van den Borne et al. (2010b) observed no differences in milk SCC between IMIs 
due to S. chromogenes and other species. In cows with transient or persistent infections (a 
quarter infected with S. chromogenes, S. epidermidis or S. simulans) the composite SCCs 
were always higher than in healthy cows (Thorberg et al., 2009). The geometric means of 
quarter milk SCCs were 225 700 cells/ml in quarters infected with S. chromogenes, 
130 000 cells/ml in quarters with S. simulans and 84 600 cells/ml in quarters with S. 
xylosus (Supré et al., 2011). The authors concluded that the elevated quarter SCCs of S. 
chromogenes, S. simulans and S. xylosus IMIs  were  comparable  with  IMI  caused  by  S. 
aureus.  
1.3.2 Milk production 
 
An increased SCC is generally associated with lower milk production (Hortet and Seegers, 
1998). Reduction in milk yield associated with SCC of 200 000 cells/ml in primiparous 
cows was 0.4-5%, and 3-11% in multiparous cows without clinical mastitis. Production 
losses increased with the higher SCC (Hagnestam-Nielsen et al., 2009). 
  
 With CNS mastitis production losses are still under discussion. It has been considered 
that cows with CNS infection may be higher yielding compared with other cows (Gröhn et 
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al., 1995). In Finland, Myllys and Rautala (1995) found that genetic production potential 
was higher for heifers with mastitis, but their actual production was lower than expected. 
In a recent study by Piepers et al. (2010) it was suggested that the higher milk production 
of cows infected with CNS might be related to the lower incidence of clinical mastitis 
during the first lactation. In another study from Canada, no difference was recorded in the 
total milk production between CNS-infected and non-infected cows (Paradis et al., 2010a). 
 
During the acute stage of CNS mastitis, reduction in milk production in primiparous 
cows was 3.2 kg/day and a week later between 1-3 kg/day (Gröhn et al., 2004). In the 
same study, no drop in milk production was recorded for the older cows, but they 
produced more milk before the diagnosis of CNS mastitis than the control cows. 
According Thorberg et al. (2009), transient infections with S. simulans resulted in 
significantly lower milk production than for healthy cows or cows with persistent S. 
simulans infection. Altogether, cows with transient infection had significantly lower milk 
production than cows with persistent CNS infection.  
 
Studies of quarter milk production losses are not yet available, but with new automatic 
milking recording systems such data will be available in the future.  
1.3.3 Possible protective effect of CNS intramammary infection 
 
The normal microbiota of the teat skin, including CNS, may protect the udder from 
pathogenic bacteria (De Vliegher et al., 2003). Competitive exclusion could prevent 
colonization of the teat by pathogenic bacteria. Colonization of the teat apex by CNS-
protected quarters from infections caused by major pathogens (Matthews et al., 1990; 
Piepers et al., 2011), and prepartum colonization with CNS did not predispose quarters to 
IMIs caused by CNS after calving (De Vliegher et al., 2003).  
 
CNS infection has been suggested to protect the quarter from other pathogens 
(Matthews et al., 1990; Lam et al., 1997a). Cows with CNS IMI during the beginning of 
lactation have lower incidence of clinical mastitis than non-infected ones (Piepers et al., 
2010). In contrast, pre-calving IMI with CNS did not protect from mastitis caused by 
major pathogens after calving (Compton et al., 2007) and a preceding CNS infection had 
no effect  on Str. uberis or S. aureus infections (Zadoks et al., 2001). Lam et al. (1997a) 
concluded that the protective effect of Corynebacterium bovis was greater than that of 
CNS.  
 
Protective effects against S. aureus infection were found in experimental studies with 
quarters naturally infected by Staphylococcus spp. (Matthews et al., 1990; Matthews et al., 
1991; Nickerson and Boddie, 1994), but quarters were more susceptible to challenge with 
S. agalactiae (Nickerson and Boddie, 1994). Protective effects against S. aureus infection 
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were found in experimental studies using S. epidermidis or S. chromogenes (Linde et al., 
1980).  
 
The suggested protective effect is probably at least partly based on the higher milk 
SCC  resulting  from  CNS  IMI  (or  caused  by  other  bacteria).  The  host  immune  response  
can then rapidly react to invading pathogens. Another explanation is inhibitory substances 
secreted by the bacteria in the milk that prevent growth of other bacteria (Matthews et al., 
1990; De Vliegher et al., 2004). Nascimento et al. (2005) found that 6% of CNS mastitis 
isolates produced bacteriocins that can inhibit growth of some strains of Listeria spp., Str. 
agalactiae, S. aureus and other CNS. CNS can also secrete lysostaphin, metalloenzyme, 
which was first reported to be produced by S. simulans (Kumar, 2008). Lysostaphin 
breaks down the bindings of the cell wall of S. aureus. 
1.4 Ecology and epidemiology  
 
Several bacterial species, including some CNS, are found from among the normal 
microbiota in the end of the teat canal (Gill et al., 2006). A wide distribution of different 
CNS species is found in herds. Studies concerning ecology and epidemiology of different 
species are rare. CNS are not strictly environmental or contagious pathogens, but species 
can  differ  in  this  respect.  In  the  study  by  Piessens  et  al.  (2011),  consisting  of  milk  and  
environmental samples from 6 dairy farms in Belgium, 23 different Staphylococcus 
species were found. S. chromogenes and S. epidermidis were predominantly isolated from 
milk, and S. haemolyticus and S. simulans were found both in milk and in the 
environment. Environmental Staphylococcus species included S. equorum, S. sciuri, S. 
fleurettii, S, cohnii, S. devriesei, S. xylosus, S. arlettae and S. succinus. Taponen et al. 
(2008) found S. succinus, S. xylosus, S. chromogenes, S. saprohyticus and S. sciuri from 
extramammary sites. Contrary to the findings of Piessens et al. (2011), S. simulans was 
seldom detected in samples from extramammary sites. Before genotyping, De Vliegher et 
al. (2003) reported that 20% of heifers harboured S. chromogenes on  the  teat  apex,  and  
herd prevalences ranged from 10 to 83%.  
 
In cows infected by CNS, a strong within-cow clustering of CNS has been found 
(Osterås et al., 2006; Ericsson Unnerstad et al., 2008). Also a within-herd clustering effect 
(OR=1.4, p<0.001) was found (Osterås et al., 2006). Prevalence of S. epidermidis can be 
15-62% in single herds (Thorberg et al., 2009; Perry et al., 2010). This indicates the 
possibility of the contagious character of this species, as for S. aureus. On the other hand, 
Piessens et al. (2011) and Taponen et al. (2008) reported the same genotypes in isolates 
from the milk and the environment. It is possible that different species and strains behave 
in different ways.  S. epidermidis probably originates from humans as the same genotype 
was found in milkers as in bovine IMIs (Thorberg et al., 2006; Jaglic et al., 2010). 
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1.5 Characteristics of bacteria 
CNS species can differ in their pathogenicity, but very little is known about their putative 
virulence factors. Virulence studies on CNS have mostly concerned isolates from humans. 
The studies have mainly focused on S. epidermidis,  which  is  an  important  cause  of  
nosocomial infections (Piette and Verschraegen, 2009). The best known virulence 
characteristic of CNS is the ability to form biofilms (von Eiff et al., 2002). Studies on 
CNS virulence genes are scant. Genotypic methods for detecting putative virulence genes 
of CNS are still under development (Vernozy-Rozand et al., 1996; Nemati et al., 2008; 
Park et al., 2011b). Primers are usually designed for S. aureus genes and the sequence 
homology can vary among species.  
 
High within species diversity is found among herds (Gillespie et al., 2009). This 
character is suspected to represent one characteristic of S. epidermidis that  helps  it  to  
succeed in nosocomial infections (Schoenfelder et al., 2010). It has numerous mobile 
genetic elements and insertion sequences in the genome, although a single clone (ST2) 
was detected in hospitals from 13 different countries (Schoenfelder et al., 2010). It is 
believed that diversification is based on genetic recombination, in contrast to S. aureus 
(Schoenfelder et al., 2010). 
1.5.1 Biofilm production 
Biofilm-producing isolates have been reported for many CNS species, especially in S. 
epidermidis (Tormo et al., 2005; Oliveira et al., 2006). Biofilm prohibits host immune 
defence by impairing phagocytosis and production of antimicrobial peptides by epithelial 
cells and neutrophils (Costerton et al., 1999). Biofilms also protect bacteria from 
antimicrobial therapy (Costerton et al., 1999; Cucarella et al., 2004; Melchior et al., 2006). 
Biofilm formation is a process where bacteria accumulate and adhere to the surfaces of 
live tissues or e.g. medical devices. Bacteria in the biofilm start to signal to each other and 
the biofilm matures. Occasionally some bacteria detach from the biofilm and disseminate 
into the environment (Costerton et al., 1999; Otto, 2008). 
 
Biofilm consists of polysaccharide intercellular adhesin (PIA) encoded by the 
intercellular adhesion icaADBC operon (Stevens et al., 2008) and accumulation-
associated, autolysin and biofilm-associated proteins, encoded by aap, atlE, bap and bhp 
(Rohde et al., 2005; Ziebuhr et al., 2006). Slime producing ability is sometimes congruent 
with biofilm production, but phenotypic biofilm studies reveal differences between 
isolates. Strong PIA production is usually associated with slime production.  
 
Biofilm production is suspected to be one reason for persistent mastitis, but strong 
evidence for that has not been presented. However, in human infections with prosthesis 
and devices, association is quite firm (Costerton et al., 1999). Research on biofilms is 
intensive, but many phenomena related to this characteristic of bacteria are still open.  
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1.5.2 Other virulence factors 
Adhesion genes have been detected in CNS species isolated from animal and human 
infections (von Eiff et al., 2002; Seo et al., 2008). Genes encoding adhesion proteins are 
termed MSCRAMM (microbial surface components recognizing adhesive matrix 
molecules). In a study by Seo et al. (2008), the eno gene, encoding laminin binding 
protein, was the most prevalent MSCRAMM gene detected in CNS. CNS isolated in 
mastitis can produce several toxins and enzymes, such as haemolysin, leucocidin, lipase, 
proteases, and DNAase (Scheifele et al., 1987; Watts and Owens, 1987; Zhang and 
Maddox, 2000). Zhang et al. (2000) found metalloproteases in several CNS species 
isolated from bovine mastitis, but particularly in S. chromogenes. 
 
 In a recent study by Park et al. (2011b), classical superantigen genes, including 
staphylococcal enterotoxins (SE), were found in one third of CNS isolates from bovine 
mastitis. The most prevalent SE genes were selq, seb and seln. In a Japanese study, 60-
70% of CNS isolates from chronic or subclinical IMIs, produced toxic shock syndrome 
toxin-1 (TSST-1) and similar amount of isolates produced SE-C. In acute CNS mastitis 
the prevalence of SE-C producing isolates was only 20% and 7% produced TSST-
1(Kuroishi et al., 2003). In contrast, Nemati et al. (2008) did not detect any enteroxin 
genes, which result may depend on differences in methodology. 
 
One in vitro internalization study showed that the adhesion capacity of CNS isolated in 
mastitis was equal to that of S. aureus strains but the invasive capacity was lower in 
general. Intracellular replication rates varied among CNS isolates. Differences between 
isolates originating from transient and persistent infections were not found (Hyvönen et 
al., 2009). 
1.5.3 Antimicrobial resistance 
Emerging antimicrobial resistance among CNS is a concern in veterinary and human 
medicine. Compared with S. aureus, CNS are more often resistant to several 
antimicrobials (Myllys et al., 1998). Resistance patterns differ among CNS species 
(Sampimon et  al.,  2011) and regions.  The role of CNS as a reservoir of resistance genes 
has been discussed and some evidence for it is available (Juuti et al., 2005; Sampimon et 
al., 2011). On the basis of the staphylococcal cassette chromosome mec (SCCmec), it 
seems that CNS are a heterogeneous group (Ibrahem et al., 2009). The possible role of S. 
fleurettii as the origin of the mecA gene has been suggested (Tsubakishita et al., 2010). 
 
In the Finnish mastitis survey, 32% of CNS isolated from subclinical IMI were 
resistant to benzylpenicillin and 10% to oxacillin (Pitkälä et al., 2004). In a limited clinical 
study, beta-lactamase production (penicillin resistance) was observed in 19% of isolates 
and was slightly more common in isolates from subclinical mastitis (23%) than from 
clinical mastitis (16%) (Taponen et al., 2006). The same finding was also reported from 
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Sweden (Persson Waller et al., 2011). In a Norwegian mastitis survey, 36% of CNS 
isolates were resistant to penicillin (Osterås et al., 2006). In a study from the USA, CNS 
isolated from older cows near calving were more often resistant to penicillin than isolates 
from primiparous cows; the respective proportions of resistance were 39% and 26.5% with 
no significant difference. Resistance to oxacillin was less than 5% in both groups (Rajala-
Schultz et al., 2004). 
 
In a recent study from the Netherlands, a very high proportion, 87.1%, of all CNS 
isolated from bovine IMI were penicillin resistant (carried blaZ and/or mecA gene) and 
14.1% were meticillin-resistant (positive for mecA) (Sampimon et al., 2011). Meticillin- 
resistance was most common in S. epidermidis, 30% of which carried mecA. Overall, 
nearly half of S. epidermidis isolates were multiresistant. The most common CNS isolated, 
S. chromogenes, carried mainly the blaZ gene (72% of the isolates) (Sampimon et al., 
2011). Proportions of penicillin-resistance differed among CNS species in Sweden; the 
highest resistance rate was found in S. epidermidis and S. haemolyticus (41%)  and  the  
lowest in S. chromogenes and S. simulans (none or only few ?-lactamase positive isolates) 
(Persson Waller et al., 2011). 
1.6 Therapy  
CNS infections have a high likelihood of spontaneous cure without the need for specific 
treatment. In about half of the IMI caused by CNS, infection is eliminated spontaneously 
(Taponen et al., 2006; Thorberg et al., 2009; Supré et al., 2011). Reported spontaneous 
cure rates in CNS mastitis range between 16% and 70% (Timms and Schultz, 1987; 
McDougall, 1998; Wilson et al., 1999; Deluyker et al., 2005). If necessary, antimicrobial 
therapy can be used to treat clinical mastitis caused by CNS, in subclinical, persistent 
cases and for dry cow therapy. Results of antibiotic treatment are good, although their 
economic benefits are questionable.  
 
In the study of Taponen et al. (2006) bacterial cure rate in CNS mastitis was 86% with 
intramammary benzylpenicillin treatment and that for penicillin-resistant isolates was 
66.7% (treated with intramammary cloxacillin or with a combination of ampicillin and 
cloxacillin), lower than for penicillin sensitive isolates (88.4%). Differences in cure rates 
after antimicrobial treatment among CNS species may occur, but to date there are few 
reports on this (van den Borne et al., 2010b).  
 
Results for Staphylococcus spp. (CNS and  S. aureus) reported in a meta-analysis by 
Halasa et al. (2009a) indicated increased cure rates for infections using dry cow therapy, 
but there was no evidence of the treatment being able to prevent new infections (Halasa et 
al., 2009b).  
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Prepartum antibiotic treatment has been proposed for control of CNS mastitis in 
problem herds and intramammary and parenteral treatments have been tested. Most studies 
have focused on heifers in herds with a high prevalence of CNS IMIs (Oliver et al., 2003; 
Borm et al., 2006; Andrew et al., 2009). In a US study, one tube of cephapirin 
intramammary lactating cow product was infused into all quarters of heifers 10-21 d 
before expected parturition (Borm et al., 2006). In the treatment group 79% of quarters 
were cured and infection was eliminated spontaneously from 31.7% of the untreated 
control quarters. Treatment had no effect on milk production, milk SCC, or reproductive 
performance during 200 d after parturition. Risk for antibiotic residues in milk after 
calving of heifers treated prepartum is a cause for concern; in one study residues were 
found in 8.8% of samples taken at the sixth milking postpartum (Andrew et al., 2009). In 
that study, intramammary cephapirin lactating cow product was used in the treatment. 
1.7 Predisposing factors and prevention of CNS mastitis 
The five-point plan (Bramley and Dodd, 1984), or the recently recommended 10-point 
prevention and control programme (National Mastitis Council, 2009), are generally 
assumed to control CNS infections. However, it has been suggested that these 
programmes do not reduce the incidence of CNS mastitis as efficiently as for mastitis 
problems associated with S. aureus or other major pathogens (Sampimon et al., 2009). The 
exact reason for this is not known, but some risk factors for CNS mastitis have been 
identified. 
 
In some studies grazing has increased occurrence of CNS mastitis (Sampimon et al., 
2009), possibly due to a heavy fly load increasing the risk of CNS mastitis during summer. 
Flies (especially Haematobia irritans) have been found to transmit S. aureus infections 
(Owens et al., 1998). In a Canadian study, heifers had a higher SCC in summertime and 
the majority of infections were caused by CNS (Olde Riekerink et al., 2007). Overall, the 
bulk SCC in herds is usually higher during summertime (Lievaart et al., 2007). Poor 
quality drinking water was reported to be another risk factor associated with CNS mastitis 
(Sampimon et al., 2009) and during the outdoor season animals drink from sources other 
than tap water.  
 
Keeping dry cows in a single group instead of in two groups increased the risk of CNS 
infection (Sampimon et al., 2009), possibly leading to milk leaking into the stalls and 
inadequate feeding during the dry and transition period. Inappropriate feeding can also 
cause udder oedema, which is known to be a mastitis risk factor (Waage et al., 2001; 
Compton et al., 2007). In Finland, dry and lactating cows are often kept together. This 
system was not included in the Dutch study (Sampimon et al., 2009), but could increase 
the risks of having even more CNS IMIs. Olde Riekerink et al. (2008) reported a 
significant difference in the incidence of clinical mastitis caused by CNS between tie-stalls 
(1.58) and free-stalls (0.68) (p<0.05). In Finland, 60% of cows were kept in tie-stalls in 
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2010, which might account for the high prevalence of CNS IMIs (Pitkälä et al., 2004; 
Koivula et al., 2007). 
 
Heifers  with  reproductive  disorders  (dystocia,  retained  placenta,  twin  birth,  
endometritis, pyometra) had an increased risk for having veterinary-treated mastitis 
(Svensson and Hultgren, 2008). Moving a heifer to the calving area on the same day 
instead of at an earlier time increased the risk of mastitis. This was also found by Kalmus 
et al. (2006). Mastitis after calving caused by CNS was decreased if the cow was dried-off 
gradually (Newman et al., 2010). 
 
Good housing hygiene and udder clipping prior to calving have decreased CNS 
infections in heifers (Piepers et al., 2011). Also teat dipping has decreased the incidence of 
CNS infections. Incidence rate of CNS mastitis decreased using post-milking teat dipping 
(Schukken et al., 1989) or dipping the teats before parturition (Piepers et al., 2011). 
Discontinuation of teat dipping increased CNS IMIs (Lam et al., 1997b).  
 
 
2 The innate immunity of the mammary gland 
The innate immune response represents an early stage of the nonspecific host response to 
infections. It does not remember previous pathogens, but is activated by any bacteria. 
After pathogens invade the udder they are recognized via conserved bacterial structures 
termed microbe–associated molecular patterns (MAMP). Bacterial MAMPs are 
recognized by the nucleotide-binding oligomerization domain (NOD)–like receptors and 
toll-like receptors (TLR) on membranes and in the cytosol of, for instance, macrophages 
and mammary epithelial cells (Inohara et al., 2005; Rainard and Riollet, 2006). Different 
NODs and TLRs recognize different MAMPs. TLR2 have ligands for peptidoglycan and 
lipoteichoic acid (LTA) in Gram-positive bacteria. NOD2 recognizes the bacterial 
peptidoglycan fragment N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) (Inohara et al., 
2005). LTA and MDP are the major MAMPs of staphylococci (Bougarn et al., 2010). 
 
Pathogens, including CNS, invade the udder via the teat canal. During the dry period 
the  canal  is  closed  with  a  waxy  keratin  plug  that  immobilizes  bacteria  and  has  
antimicrobial activity (Rainard and Riollet, 2006). A keratin layer protects the teat also 
during lactation. Sphincter muscles seal the teat canal between milkings. After milking, 
the teat canal closes within about two hours (Rainard and Riollet, 2006).  
2.1 Cellular defence 
After a pathogen is recognized, a complex signalling system is activated and secretion of 
proinflammatory cytokines and chemokines begins (Bougarn et al., 2010). Leucocytes 
invade the mammary gland and milk compartment. The cellular innate immune defence 
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consists of neutrophils, lymphocytes (T and B), macrophages, natural killer cells (NK-
cells) and dendritic cells (Rainard and Riollet, 2006). Also epithelial cells take part in the 
immune response by recognizing the pathogen and expressing some cytokines, 
antimicrobial peptides and Lf (Brock, 2002; Tosi, 2005; Lippolis, 2008). 
 
Neutrophils are recruited to the infection site rapidly (Sordillo, 2005). They have many 
functions, being phagocytic cells, and secreting antibacterial factors (Sordillo, 2005). 
Macrophages are phagocytic and antigen-presenting cells and detect invading pathogens. 
They are involved in the initiation of the inflammatory response. Macrophages secrete 
prostaglandins, leukotriens and cytokines and are stimulated by cytokines (Sordillo and 
Streicher, 2002). NK-cells are granular lymphocytes with cytotoxic activity and can kill 
both Gram-positive and Gram-negative bacteria (Sordillo and Streicher, 2002). They are 
induced by several cytokines (Tosi, 2005).  
 
The milk SCC, the most commonly used indicator of mastitis consists of neutrophils, 
macrophages, epithelial cells and mononuclear cells. In the healthy quarter, macrophages 
are the predominant cell type in milk SCC, but during inflammation the proportion of 
neutrophils increases up to 90% (Pyörälä, 2003). 
2.2 Humoral defence 
Together with the cellular defence mechanism, soluble substances of the innate immune 
system represent a complex network. In addition to the direct effects on bacteria, 
signalling and immunoregulation are a major part of functions of the humoral defence 
system.  
 
An additional group of proteins, representing a complement system, excreted by 
macrophages and monocytes, is involved in both the innate immune response and acquired 
immunity (Sordillo and Streicher, 2002). These proteins are involved in lysis of bacteria, 
and opsonization and attraction of phagocytes (Sordillo and Streicher, 2002). In mastitis, 
the alternative pathway of the complement system is used. After activation, the 
complement  system  opsonizes  bacteria  with  C3b  and  C3i  and  generates  the  
proinflammatory fragment C5a, which also stimulates the phagocytic function of 
neutrophils (Rainard and Riollet, 2006). Initial concentrations of C5a vary among cows 
and the specific pathogen also affects the complement response (Rainard and Poutrel, 
2000; Bannerman, 2009). In experimental IMI induced by S. aureus, C5a concentrations 
did not increase (Riollet et al., 2000; Bannerman et al., 2004b). 
 
The antimicrobial peptides as defensin and lysozyme are secreted by epithelial cells 
and neutrophils (Tosi, 2005) and have broad antimicrobial activity and some 
immunoregulatory properties (Tosi, 2005). Lysozyme is a bactericidal protein that can act 
with complement and Lf. Not all pathogens are sensitive to lysozyme, but it cleaves 
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linkages in the peptidoglycan of the cell wall of Staphylococcal spp.(Rainard and Riollet, 
2006).  
 
Mastitic milk contains the enzyme lactoperoxidase, which acts through its active 
metabolite hypothiocyanate and is bacteriostatic for Gram-positive and Gram-negative 
bacteria (Sordillo and Streicher, 2002). Xanthine oxidase, an enzyme of the membrane of 
milk fat globulins, is a bactericidal agent in the milk (Rainard and Riollet, 2006). Natural 
opsonic antibodies are present in bovine serum and milk, and can opsonize nonspecific 
bacteria in the milk. Natural antibodies, which are produced without any special infection, 
are present before the adaptive immune response is activated. They can neutralize toxins 
detected in the milk and serum, for example staphylococcal leukotoxin (Loeffler and 
Norcross, 1985). Transferrin and Lf are iron-binding proteins in the milk. Transferrin is 
not synthesized in the udder, but comes from the blood serum (Rainard and Riollet, 2006).  
2.2.1 Lactoferrin  
Lactoferrin is an iron-binding glycoprotein that exerts an antimicrobial effect on bacteria, 
yeasts, fungi and viruses, as well as immunomodulatory and anti-inflammatory activities 
(Nuijens et al., 1996; Brock, 2002; Kawai et al., 2007). Lf is present in milk, bile, saliva, 
tear fluid and granules of polymorphonuclear cells (PMN) (Nuijens et al., 1996). Lf is 
secreted from epithelial cells of the mammary gland and is found in the secondary 
granules of neutrophils (Brock, 2002). 
 
The concentration of Lf in bovine milk varies according to the lactation period: during 
the dry period and colostral phase, the concentration of Lf reaches its maximum (Welty et 
al., 1976; Nuijens et al., 1996). Lf concentration in milk decreases rapidly after parturition 
and remains low throughout the lactation (Nuijens et al., 1996). The concentration of Lf in 
milk increases during mastitis. Harmon (1975) and Chaneton (2008) found differences in 
Lf concentrations in milk from quarters with mastitis caused by different pathogens, which 
may reflect the intensity of the inflammation or indicate differences in the response of the 
mammary gland mediated by Lf secretion. 
 
Bacterial species and strains differ in their sensitivity to lactoferrin. Studies on the in 
vitro susceptibility of mastitis-causing bacteria to Lf have shown good to moderate 
activity of Lf against Staphylococcus aureus and CNS (Aguila et al., 2001; Kutila et al., 
2003a; Hyvönen et al., 2009). Lactoferrin has bacteriostatic activity with its iron ion 
chelating properties (Nuijens et al., 1996). It also inhibits the ability of staphylococci to 
form biofilm (Leitch and Willcox, 1999b). The bactericidal activity increases the 
permeability of the bacterial cell membrane and affects the metabolic activity of the 
bacterial cell (Nibbering et al., 2001). The outer wall of staphylococci consists of 
lipoteichoic acid, the anionic component of the cell wall. Lf is bound to this membrane 
and decreases its negative charge, thereby making it more vulnerable to lysozyme (Leitch 
and Willcox, 1999a). Fresh bovine Lf increased the phagocytosis of S. aureus by PMN 
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due to the enhanced opsonization of bacteria (Kai et al., 2002a).  Exposing CNS to Lf did 
not affect their adhesion or invasion to the bovine mammary epithelial cells (BME) in 
vitro, but did decrease their replication rate (Hyvönen et al., 2009). 
2.2.2 Cytokines and acute phase proteins 
The major groups of cytokines studied in the bovine IMIs are interleukins (IL), tumor 
necrosis factors (TNF) and interferons (IF) (Sordillo, 2005). Cytokines are excreted by 
different cells and they also affect diverse target cells, but their expression is tightly 
regulated (Lippolis, 2008) (Table 2).  
Table 2. Some effects of the most important cytokines related to the innate immune response to 
bovine intramammary infection (Janeway et al., 2005; Bannerman, 2009). 
  Local effect 
Systemic 
effect Induces Inhibits Characteristics 
IL-1? 
Activates vascular 
endothelium, 
lyphocyte activation 
Fever 
IL-1?, IL-6, 
IL-8, IL-12, 
TNF-?,  
APPs 
  
Proinflammatory, 
response varies 
largely between 
individuals 
IL-6 Lyphocyte activation Fever  APPs IL-1?, TNF-? Pro- and anti- inflammatory 
IL-8 
Recruits and enhances 
the functioning of 
neutrophils 
   Neutrophil attraction IL-1?, TNF-? Chemokine 
IL-10  Inhibits the inflammation   
B cell MHC 
II 
production  
 Cytokine 
release in 
macrophages 
Anti-inflammatory, 
T-cell cytokine 
IL-12 Activates NK-cells and macrophages   
IF-?, IL-8, 
IL-10, TNF-
? 
  
Link between innate 
and adaptive 
immune system  
TNF-? 
Activates vascular 
endothelium, 
increases vascular 
permeability, recruits 
neutrophils 
Fever   APPs   Proinflammatory 
 
 
Interferons are a link between the innate immune system and the adaptive immune 
system and are excreted from NK-cells, lymphocytes and monocytes (Bannerman, 2009). 
Interferon gamma enhances phagocytic activity of macrophages and neutrophils. High IF 
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concentrations have been found in persistent IMIs, when bacteria are reactivated 
(Bannerman, 2009). 
 
Acute phase proteins (APP) are induced via cytokines and synthesized by the liver. 
The acute phase response optimizes resistance to the infection and restoration of the 
normal stage (Jensen and Whitehead, 1998). The most important APPs in mastitis are 
haptoglobin (Hp), lipopolysaccaharide binding protein (LBP) and serum amyloid A 
(SAA). SAA is synthesized by the liver and also in the mammary gland by the epithelial 
cells (Jacobsen et al., 2005a; Weber et al., 2006). SAA has been suggested to have many 
immunological roles: it activates leucocytes by chemotaxis, increases phagocytosis and is 
able to enhance leucocyte adhesion to the endothelial cells (Suffredini et al., 1999). In 
healthy  quarters  the  concentrations  of  milk  amyloid  A (MAA) are  low (Grönlund et  al.,  
2005; Åkerstedt et al., 2007). In mastitis, the concentration of MAA differs according to 
pathogen (Pyörälä et al., 2011).  
 
As with MAA, the Hp concentration in milk of healthy quarters is often low (Grönlund 
et al., 2005; Åkerstedt et al., 2007). In mastitis, differences in Hp concentrations are 
detected according to pathogens and between severe clinical mastitis versus subclinical 
mastitis (Wenz et al., 2010; Pyörälä et al., 2011). Both MAA and Hp varied greatly in 
milk of subclinical mastitis cases (Grönlund et al., 2005). The concentration of LBP varied 
also according to pathogens and severity of mastitis (Wenz et al., 2010). In experimentally 
induced mastitis the concentration of LBS increased earlier with E. coli than with S. 
aureus, but the peak concentration was higher with S. aureus (Bannerman et al., 2004b). 
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Aims of the study 
The general aim of this thesis was to investigate pathogenesis of CNS IMI. The studies 
included in vivo studies using experimentally induced mastitis models and in vitro studies 
on the ability of CNS to produce biofilm and slime. The specific aims of the studies were 
as follows: 
1. To  develop  a  model  of  experimental  CNS  mastitis  and  to  describe  the  host  
response to S. chromogenes, S. epidermidis and S. simulans infections (I, II). 
 
2. To compare the innate immune response of the cow in experimental mastitis 
induced with two species of CNS, S. epidermidis and S. simulans (II). 
 
3. To compare the innate immune response of spontaneously eliminated or persistent 
CNS infections in experimental mastitis caused by S. epidermidis or S. simulans 
(II). 
 
4. To investigate the effect of a high concentration of Lf in the milk in experimental 
mastitis caused by S. chromogenes (III). 
 
5. To investigate biofilm and slime producing capability of CNS isolated in mastitis 
and the association of these characteristics with persistence of infection and 
severity of mastitis caused by these isolates (IV). 
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Materials and methods 
1 Experimental studies (I, II, III) 
1.1 Animals 
Six primiparous Holstein–Friesian cows were used in the first study (study I). They were 
30 months old (from 27 to 31 months) at parturition. The experiment was carried out 4 
weeks after calving. One cow was excluded from the study due to spontaneous S. aureus 
mastitis in one quarter.  
 
In study II, eight primiparous, mid-lactating dairy cows were used (seven Ayrshire and 
one Holstein-Friesian). Before the experimental challenge, the mean quarter milk 
production in the experimental quarters was 3.96 kg/day for S. simulans infection and 3.56 
kg/day for the S. epidermidis infection. The cows were kept in a tie-stall barn and fed with 
good-quality silage and concentrates according to the Finnish feeding recommendations 
for dairy cows. At the beginning of the study all the cows were clinically healthy.  
 
In study III, six primiparous Holstein–Friesian transgenic cows, produced and owned 
by Pharming Group NV, The Netherlands, and expressing human lactoferrin (hLf) in their 
milk,  were  used,  and  six  normal  Holstein–Friesian  dairy  cows  (study  I)  served  as  a  
controls. The median age of the transgenic cows was 40 months, and that of the normal 
cows was 30 months at parturition. Cows calved 4 weeks before the beginning of the 
experiment, and their average daily milk yield was 18.4 kg (15.8–21.2 kg) in the 
experimental cows and 25.1 kg (21.5–28.1 kg) in the control cows. The basic mean 
concentration of recombinant human lactoferrin (rhLf) in the milk of the transgenic cows 
during early lactation was 2.9 mg/ml, and that of bovine lactoferrin (bLf) was 0.07 mg/ml 
(Hyvönen et al., 2006a). 
 
Udder quarters of all cows in all studies had a low milk SCC (<100 000 cells/ml) and 
they were free from bacterial growth in two subsequent samplings before the experimental 
infection. 
1.2 Experimental designs 
Study I was our pilot study for the experimental CNS mastitis model. One quarter of each 
cow was inoculated once with S. chromogenes. In study II, each animal was infected once 
with S. simulans and once with S. epidermidis using a crossover design, with a two-week 
experimental period and two-week wash-out period. The cows were randomly allocated to 
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two groups. In the first challenge, one udder quarter of each cow was experimentally 
inoculated with either S. simulans or S. epidermidis. In the second challenge, another 
quarter of each cow was inoculated with the other CNS species. Study III included the 
experimental group (transgenic cows) and the control group (normal cows, study I). Both 
groups were challenged once with the same CNS strain, S. chromogenes. 
 
In all studies, infection was interpreted as a persistent infection if the inoculated strain 
was detected in the milk sample at the final sampling time two weeks post cahallenge 
(PC), and the elimination of bacteria was confirmed when no growth of the inoculated 
strain was detected in two successive samplings. In study II, if the infection persisted over 
the first experimental period, the infected quarter was treated with an intramammary 
antibiotic at the beginning of the wash-out period (S. simulans with Carepen® 600 mg 
procaine penicillin G (Vetcare Oy, Finland) and S. epidermidis with Wedeclox mastitis® 
1000 mg cloxacillin (WDT, Garbsen, Germany), both once a day for 3 days), and 
clearance  of  the  infection  was  confirmed  with  bacteriological  examination  of  a  milk  
sample on three consecutive days. Otherwise the cows did not receive any medical 
treatment during the study periods. 
1.3 Ethical considerations 
The  ethics  committees  of  Helsinki  University  (I,  II,  III)  and  Kuopio  University  (III)  
approved the study protocols, and the Board for Gene Technology in Finland approved the 
use of transgenic animals (III). 
1.4 Bacterial strains 
The S. chromogenes strain  PM37  (I,  III)  was  isolated  from  a  case  of  bovine  clinical  
mastitis (Taponen et al., 2006). In study II, the S. simulans (PM198) and S. epidermidis 
(PM221) strains were isolated from persistent subclinical IMI from two dairy cows. Both 
strains had persisted for several months in the mammary quarters of the cows, causing 
subclinical mastitis. Infection by S. simulans increased milk SCC of the affected quarter to 
a maximum of 2 269 000 cells/ml and to a minimum SCC of 356 000 cells/ml, and 
infection by S. epidermidis to a maximum SCC of 1 177 000 cells/ml and a minimum SCC 
of 154 000 cells/ml (Taponen et al., 2007). 
 
The experimental strains were identified using conventional methods (Hogan et al., 
1999) and using amplified fragment length polymorphism (AFLP). S. chromogenes strain 
PM37 was tested for sensitivity to Lf in vitro with the method of (Kutila et al., 2003b); 
growth of the strain was inhibited in whey at  a concentration of Lf >1.67 mg/ml.  The S. 
epidermidis strain  produced  biofilm  in  the  tissue  culture  plate  assay  (TCP)  and  was  
resistant to benzylpenicillin. In an in vitro study by Hyvönen et al. (2009), these CNS 
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strains showed an ability to adhere to and invade mammary epithelial cells. For S. 
chromogenes intracellular replication was markedly higher than for the other CNS strains 
studied. All strains were stored at ?80 °C (Microbank®, Pro-Lab Diagnostics, Neston, 
Cheshire, UK). 
1.5 Inoculation procedure 
Before inoculation the bacterial strains were refreshed by culturing on blood agar 
(Tammertutka®, Finland) at 37 °C for 18 h. Two colonies were transferred to Müller–
Hinton  broth  (Becton  Dickinson,  Difco,  France)  and  cultured  at  37  °C  for  18  h.  The  
density of the bacterial suspension was determined with a spectrophotometer at 550 nm. 
The bacterial culture was pelleted by centrifugation and washed several times with 
phosphate buffered saline (PBS).  
 
The suspension was diluted in saline to 300 000 CFU/ml in studies I and III. The 
inoculate contained approximately 2.1 × 106 CFU  in  7  ml  of  saline.  In  study  II  the  
suspension was diluted in saline to 800 000 CFU/ml. The inoculate contained 5.7 x 106 
CFU in 7 ml of saline. The suspension was cultured on blood agar plates in a dilution 
series, and colonies were counted to determine the final inoculum dose. The infection dose 
used was based on a pilot study in two cows that received different doses of the same S. 
chromogenes strain. The aim of the study was to induce clinical mastitis. The first 
preliminary testing with a dose of 50 000 CFU did not provoke any clinical signs and 
bacteria were eliminated from the quarters within 6 h post-inoculation. 
  
One udder quarter of each cow served as an experimental quarter, and another quarter 
as a control. Experimental quarters were challenged through the teat canal using a blunt 
cannula within 30 min of the morning milking. Prior to infusion, the teat end was 
disinfected with chlorhexidin (5 mg/ml). After the infusion, the teat was gently closed 
with the fingers, and the inoculation dose was massaged upwards. Control quarters were 
kept intact in studies I and III. In study II, the control quarters were infused with 7 ml of 
PBS. 
1.6 Milk and blood samples 
Blood samples were collected 2 h before the challenge and at 12, 22, 30, 34, 46, 54, 72 
and 96 h PC (I & III). In study II, blood samples were collected at 24 h and 0 h before the 
challenge and then at 4, 6, 12, 21, 27, 30, 36, 45, 69, 93, 117 and 141 h, and on the 7th, 10th 
and 14th day PC. Serum was separated and serum samples stored at ?80 °C for later 
determination of SAA (I, II, III) and cytokines (II).  
  
 
 
 
32
Milk samples were taken from the experimental and control quarters for 
bacteriological culturing, SCC, and determination of concentrations of cytokines IL-1?, 
IL-8, tumor necrosis factor ? (TNF-?), milk N-acetyl-?-d-glucosaminidase (NAGase) 
activity, and concentrations of rhLf, bLf and MAA. Aseptic milk samples were collected 
2 h prior to the challenge and then at 8, 12, 22, 30, 34, 46, 54, 72, 78, and 96 h, and on the 
7th and 14th days  PC  (I,  III).  In  study  II  milk  samples  were  collected  at  24  and  0  hours  
before the challenge and then at 4, 6, 12, 21, 27, 30, 36, 45, 54, 69, 78, 93, 102, 117, 126, 
and 141 hours, and on the 7th, 10th, and 14th day PC. In all studies milk samples were 
stored at ?80 °C for later determinations. 
1.7 Clinical examination 
The  cows  were  examined  clinically  at  every  sampling.  Clinical  status  consisted  of  the  
general attitude of the cow, appetite, body temperature, rumen function, consistency of the 
udder and milk appearance. Signs were divided into three groups: systemic signs, local 
signs and milk appearance. The scoring system was adapted from Anderson et al. (1986), 
with slight modifications (scoring from 1 to 3, half numbers also used). Signs were scored 
according to their severity (1 = no signs or changes and 3 = severe signs or changes). The 
total and quarter milk yield of the cows was measured during the experimental period.  
Additionally, in study II hock-to-hock distance was measured to indicate possible pain at 
each sampling time according to Kemp et al. (2008). 
 
2 Field studies (IV)  
A total of 244 CNS isolates were used, of which 192 were isolated from milk samples 
from bovine mastitis and 52 CNS were reference or type strains. Additionally, two S. 
aureus reference strains were included. Mastitis isolates originated from previous studies 
by Taponen et al. (2006; 2007) and were isolated from milk of 138 cows from 62 
commercial dairy herds. Sample collection, bacterial culturing and species identification, 
as well as classification of clinical data and persistence of infection, were previously 
described (Taponen et al., 2006; Taponen et al., 2007). In brief, milk samples were 
cultured using standard methods (Hogan et al., 1999). Species identification was initially 
performed using API Staph ID 32 tests (bioMérieux, Marcy l’Etoile, France) and 
confirmed with AFLP analysis. Clinical and subclinical mastitis were defined as described 
by the International Dairy Federation (1999). A total of 35% of milk samples originated 
from clinical mastitis. Follow-up samples were collected 3-4 weeks after the initial 
sample. If the same API phenotype and/or AFLP genotype was detected in the follow-up 
sample, the case was defined as a persistent infection. Association of biofilm formation of 
the strain with persistency of IMI was studied using 118 isolates, which originated either 
from IMIs not treated with antimicrobials (110) or from IMIs treated with antimicrobials 
but remaining infected (8). 
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The main groups of CNS species included in the study were S. simulans (57 isolates), 
S. chromogenes (55), S. haemolyticus (18),  and  S. epidermidis (10). Additionally, 52 
isolates of other CNS species were included (S.spp group). 
 
The reference strain S. epidermidis ATCC 35984 was used as a positive control strain 
(Gill et al., 2005) and S. epidermidis ATCC  12228  as  a  negative  control  (Zhang  et  al.,  
2003) in the phenotypic biofilm and slime assays. The control strains for biofilm-
associated genes are presented in Table 4. 
All isolates (n=244) were included in the TCP and Congo Red Agar plate (CRA) 
analyses, whereas fluorescent in situ hybridisation (FISH) analysis was performed for 170 
isolates (randomly selected 123 mastitis isolates and 47 reference strains). A total of 131 
isolates were included in the PCR gene detection analysis (84 mastitis isolates from most 
common species and 49 reference strains).  
 
 
3 Analytical methods  
3.1 Bacterial culturing (I, II and III) 
In experimental mastitis studies a volume of 100 ?l of milk was cultured on blood agar 
and  several  dilutions  of  the  milk  samples  were  cultured  for  bacterial  counting;  the  
detection limit for bacterial growth was 10 CFU/ml. Colonies were identified as CNS 
using standard procedures (Hogan et al., 1999), and in unclear cases the API Staph ID 32 
test was used. In study II, the isolates detected in the quarters with persistent infection 
were confirmed to be identical to the challenge strain by ribotyping using HindIII 
restriction enzyme and oligonucleatide probes targeting the 16 and 23S rRNA encoding 
genes (Regnault et al., 1997). 
3.2 Indicators of inflammation in the milk  
3.2.1 Somatic cell count (I, II and III) 
SCC was determined by a fluoro-optical method using the Fossomatic-instrument in Valio 
Ltd. Laboratories, Finland. 
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3.2.2 N-acetyl-?-D-glucosaminidase (I, II, III, IV) 
Milk NAGase activity was used as an indicator of inflammation in the udder quarters. 
Milk NAGase activity was measured using the fluorogenic method (Kitchen et al., 1978) 
with an in-house microplate modified by Mattila and Sandholm (1985). The calibrated 
milk sample was replaced with a control milk sample of known 4-methyl-umbelliferon (4-
MU) concentration, and NAGase activity was expressed in picomoles of 4-MU/min/µl for 
milk at 25 ?C.  
 
Using this method, the NAGase activity of normal milk (SCC <100 000 cells/ml) was 
0.049–0.062 pmol 4-MU/min per ?l of milk at 25 °C in studies I and III. Inter-assay and 
intra-assay coefficients of variation (CV) for NAGase activity were <4.8% for the high 
control and <6.6% for the low control. 
 
In  studies  II  and  IV,  after  minor  changes  to  previously  used  analysis,  the  analysis  of  
milk NAGase activity was validated by Hovinen et al. (2010) and the normal values were 
changed to 0.06–0.84 pmoles 4-MU/min/?L milk. The upper detection limit for NAGase 
activity was 24.5 pmol 4-MU/min/µl. Inter-assay and intra-assay CVs for the new analysis 
for NAGase activity were 5% and 4%, respectively. 
3.3 Determination of cytokines (II) 
Concentrations of IL-1?, IL-8, and TNF-? in serum and milk were determined by 
sandwich enzyme-linked immunosorbent assays (ELISA) as described by Bannerman et 
al. (2003; 2004b), with some modifications. The IL-8 data were obtained using the kit’s 
own human IL-8 standard. The data were further transformed by multiplying by 100 as the 
ELISA kit detected the human recombinant IL-8 about 100 times as efficiently as bovine 
recombinant IL-8. The specific kit, anti-cytokine antibodies and protein standards used are 
given in Table 3. Whey was prepared from thawed milk samples by centrifugation (16 100 
× g,  30  min,  +4  ºC).  The  concentrations  of  measured  cytokines  were  extrapolated  from  
standard curves on each plate using Ascent Software 2.6 (Theorem Electron Oy, Vantaa, 
Finland). The intra-assay CV was <15%. 
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Table 3. The ELISA kit, anti-cytokine antibodies (ab) and cytokine protein standards used in study 
II. 
Cytokine 
ELISA kit / antibody / protein 
standard Source 
Final concentration 
and buffer 
IL-8 Human IL-8 ELISA kit DY208 R&D Systems, Minneapolis, MN  
IL-8 Recombinant bovine IL-8 
RPOIL8I Thermo 
Scientific, Waltham, 
MA  
IL-1?  Mouse anti-sheep IL-1? (capturing ab) 
MCA1658 AbD 
Serotech, Oxford, UK 4 µg/mL in PBS 
IL-1?  Recombinant bovine IL-1? PBP008 AbD Serotech 
 
IL-1?  Biotin-conjugated mouse anti-bovine IL-1? (detection ab) 
AHP851B AbD 
Serotech 
2 µg/mL in 1% 
BSA-PBS 
TNF-? Mouse anti-bovine TNF-? (capturing ab) 
MCA2334 AbD 
Serotech 1 µg/mL in PBS 
TNF-? Recombinant bovine TNF-? PBP005 AbD Serotech 
 
TNF-? Biotin conjugated mouse anti-bovine TNF-? (detection ab) 
MCA2335B AbD 
Serotech 
2.5 µg/mL in 1% 
BSA-PBS 
 
3.4 Analysis of serum amyloid A and milk amyloid A (I, II, III) 
Concentrations  of  SAA  and  MAA  were  determined  using  a  commercial  kit  (Tridelta  
Development, Wicklow, Ireland) with a detection limit of 0.005 mg/ml. Serum and milk 
samples were initially diluted 1:500 and 1:50 respectively. Dilutions 1:1000 and 1:100 
were used if results exceeded the range of the standard curve (75 mg/l and 7.5 mg/l 
respectively). The inter-assay and intra-assay CVs for the SAA and MAA analyses were 
<10% and <5%. 
3.5 Analysis of bovine and human lactoferrin (II) 
Quantitative recombinant human and natural bovine lactoferrin analyses were conducted 
with ELISA. hLf was measured with an rhLf-specific ELISA according to the procedure 
recommended by Pharming (The Netherlands), and anti-hLf was adsorbed with Sepharose 
to remove cross-reacting antibodies (van Berkel et al., 1996). bLf levels were measured 
with a bLf ELISA quantification kit (Bethyl Laboratories, Inc., Montgomery, USA). The 
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cross-reactivity of bLf with hLf was tested with bLf and hLf standards (Sigma, St. Louis, 
USA) at a level of detection of 0.008 mg/ml. The inter-assay and intra-assay CVs for the 
Lf analysis were <10% and <5%, respectively. 
3.6 Slime production ability (IV) 
Slime producing ability was studied with CRA (Tryptone Soy Agar, LabM, with 0.08% 
Congo Red, Sigma) (Freeman et al., 1989). Overnight cultures in TSB with 0.25% lactose 
of each isolate were inoculated onto CRA plates, and incubated for 24 h at 37ºC. All 
isolates were cultured twice; first with glucose and then with lactose supplementation. 
Biofilm formation was detected as black colonies on the agar, while the colonies of non-
biofilm-producers remained red (Fig. 1).  
 
 
 
Figure 1. Congo Red stains black exopolysaccharides excreted by bacteria in CRA plates. The 
negative reference strain S. schleiferi DSM 6628 and positive S. capitis DSM 6717. 
3.7 Phenotypic biofilm formation (IV) 
3.7.1 Tissue cell plate assay 
The TCP biofilm assay as described by Christensen et al. (1985) was used with slight 
modifications. All analyses were performed in triplicate. Briefly, isolates were incubated 
in  tryptone  soy  broth  (TSB)  (LabM,  Lancashire,  UK).  The  analysis  was  performed  for  
each isolate with glucose and with lactose supplementation in the broth. Lactose (0.25% 
lactose, Merck, Darmstadt Germany) was used to substitute for saccharide 
supplementation, so that the amount of lactose was comparable with that in milk. In 
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another analysis,  glucose supplementation was adjusted to the same concentration as the 
amount of glucose degraded from lactose in normal milk. Subsequently, broth suspension 
was added to the TSB (1:100) and a further 200 ?l of that solution was pipetted into flat-
bottomed tissue culture plates (Sarstedt, Nümbrecht, Germany). The plates were 
incubated, washed three times with PBS, fixed and dried before being stained with 0.1% 
crystal violet. Absorbance was determined with a multilabel microtiter plate reader (Victor 
2, Wallace, USA) at 595 nm. Every plate included a pure TSB sample (blank) and positive 
and negative controls, all in triplicate (Fig. 2). The absorbance value of the blanks was 
subtracted from the absorbance values of the isolates. Means of the three absorbance 
values of the isolate represented the result. Absorbance values > ±4 x standard deviation 
(SD) were rejected. An isolate was defined as a biofilm producer if the absorbance value 
was >0.1. The cut-off value was set according to the absorbance value of the biofilm 
negative reference strain ATCC 12228 (with a mean absorbance value of 0.08) +2 x SD 
(0.02). 
3.7.2 FISH 
Fluorescent in situ hybridization was performed using the method of Oliveira et al. (2006). 
Two 16S rRNA oligonucleotide probes were used: Sta (5´-TCCTCCATATCTCTGCGC-
3´; E. coli 697), specific for Staphylococcus spp. and  labelled  with  rhodamine  at  the  5´-
end, and Sau (5´-GAAGCAAGCTTCTCGTCCG-3´; E. coli 69) (Oligomer Oy, Helsinki, 
Finland), specific for S. aureus and labelled with fluorescein at the 5´-end. Ten well slides 
(MP Biomedicals, USA) were washed with ethanol, then with acetone and ethanol, rinsed 
with distilled water and allowed to dry. Overnight TSB-cultures of each isolate were 
diluted at 1:20 in TSB with 0.25% lactose. Ten microliters of TSB staphylococcal 
suspensions were placed in each well and incubated for 18 h and 72 h, to allow biofilm 
formation. After incubation and air-drying, the suspensions were fixed, which were then 
dehydrated, and permeabilized with lysostaphine 0.1-1mg/ml (Sigma-Aldrich). After 
permeabilization, hybridization buffer, containing 5 ng/µl of each probe, was added and 
incubated at 45 ºC for 3 h in tubes containing filter papers moistened with hybridization 
buffer. Slides were washed in a buffer solution and rinsed in sterile water. Three drops of 
Vectashield  Mounting  Medium  (Vector  Laboratories,  USA)  were  added  and  then  the  
slides were covered with slips. Slides were visualized by fluorescent microscopy 
(Olympus AX 70) at x 1000 between 515-560 and 450-490 nm. Positive and negative 
reference strains, S. epidermidis ATCC 35984 and ATCC 12228, were included in each 
assay. All isolates were tested as duplicates in each assay, and each assay was repeated 
once. 
3.8 Adhesion genes and bap, icaA and icaD genes (IV) 
The presence of nine MSCRAMM genes was determined: cna (encoding collagen binding 
protein), eno (encoding laminin binding protein), ebpS (encoding elastin binding protein), 
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fnbA and fnbB (encoding fibronectin binding protein A and B), fib (encoding fibrinogen 
binding protein), clfA and clfB (encoding clumping factor A and B), and bbp (encoding 
bone sialoprotein binding protein) (Tristan et al., 2003; Seo et al., 2008; Vautor et al., 
2008). In addition, the presence of icaA and icaD (encoding PIA production) (Cramton et 
al., 1999), and bap (encoding biofilm associated protein) (Tormo et al., 2005) were 
studied. DNA was extracted from all staphylococcal isolates. The nucleotide sequences of 
the primers (Oligomer Oy) are shown in Table 4.  
Table 4. Primers and control strains for PCR in study IV. Primers were used according to Tristan 
et al. (2003), except for icaA and icaD which were used according to Vasudevan et al. 
(2003). 
Genes Encoding protein Nucleotide sequence of primers Amplicon size (bp) 
Control 
strain 
bap biofilm associated protein 
3’-CCCTATATCGAAGGTGTAGAATT-5’ 971 1 5’-GCTGTTGAAGTTAATACTGTACCTGC-3’ 
bbp bone sialoprotein binding protein 
3’-AACTACATCTAGTACTCAACAACAG-5’ 575 2,3 5’-ATGTGCTTGAATAACACCATCATCT-3’ 
clfA  clumping factor A  3’-ATTGGCGTGGCTTCAGTGCT-5’ 292 4 5’-CGTTTCTTCCGTAGTTGCATTTG-3’ 
clfB  clumbing factor B 3’-ACATCAGTAATAGTAGGGGGCAAC-5’ 205 4 5’-TTCGCACTGTTTGTGTTTGCAC-3’ 
cna  collagen binding protein 
3’-GTCAAGCAGTTATTAACACCAGAC-5’ 423 3 5’-AATCAGTAATTGCACTTTGTCCACTG-3’ 
ebpS elastin binding protein 
3’-GTCAAGCAGTTATTAACACCAGAC-5’ 423 3,5 5’-AATCAGTAATTGCACTTTGTCCACTG-3’ 
eno laminin binding protein 
3’-ACGTGCAGCAGCTGACT-5’ 302 3 5’-CAACAGCATCTTCAGTACCTTC-3’ 
fib fibrinogen binding protein 
3’-CTACAACTACAATTGCCGTCAACAG-5’ 404 
4,5 
5’-GCTCTTGTAAGACCATTTTCTTCAC-3’ 
 
fnbA fibronectin binding protein  A 
3’-
GTGAAGTTTTAGAAGGTGGAAAGATTAG-5’ 643 4 
5’-GCTCTTGTAAGACCATTTTTCTTCAC-3’ 
fnbB fibronectin binding protein  B 
3’-GTAACAGCTAATGGTCGAATTGATACT-
5’ 524 4 
5’-CAAGTTCGATAGGAGTACTATGTTC-3’ 
icaA intercellular adhesin protein A 
3’-CCT AAC TAA CGA AAG GTA G-5’ 1315 4 5’-AAG ATA TAG CGA TAA GTG C-3’ 
icaD intercellular adhesin protein D 
3’-AAA CGT AAG AGA GGT GG-5’ 381 4 5’-GGC AAT ATG ATC AAG ATA C-3’ 
1 S. xylosus DSM 20266 (Planchon et al., 2006) 
2 S. epidermidis ATCC 35984 (Gill et al., 2005) 
3 S. aureus ATCC 25923 (Montanaro et al., 1999) 
4 S. aureus Newman (Baba et al., 2008) 
5 S. epidermidis ATCC 12228 (Zhang et al., 2003) 
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Five different PCR amplifications were carried out, four of them by means of 
multiplex PCR. PCR 1 was designed to detect genes fnbB, fib, clfA and clfB; PCR 2 for the 
genes cna, eno and bap; PCR 3 for the genes ebpS and bbp; PCR 4 for the genes icaA and 
icaD; and PCR 5 for the gene fnbA. 
3.9 Statistical methods 
In  study  I,  descriptive  statistics  was  performed  using  SPSS  13.0  software.  Results  were  
presented as means (±S.E.M.) and medians (range) of the variables. A Wilcoxon Signed 
Ranks test was used to test the statistical significance of the differences between the 
challenged and control quarters. 
 
In study II, statistical analyses were carried out using SAS version 8.2 (SAS Institute, 
Cary,  N.C.,  USA).  Data  (IL-1?,  IL-8,  TNF-?,  SCC,  milk  NAGase  activity,  bacterial  
counts,  SAA,  MAA)  were  not  normally  distributed  and  logarithmic  transformation  was  
used. Analyses among CNS species and between persistent/transient infections were 
performed using analysis of variance for the log-transformed area under the curve (AUC) 
values. When estimating the effect of CNS species, the effect of the period (first or second 
inoculation) and the sequence of the inoculation by each bacterial species (S. simulans - S. 
epidermidis versus S. epidermidis - S. simulans) were included as fixed effects in the 
models. In the analyses between persistent and transient infections the inoculation 
sequence of the bacterial species was also included in the model. ANCOVA for repeated 
measurements was used for analysis of milk production and comparison of concentrations 
of cytokines (IL-1?, IL-8, and TNF-?) in milk between the experimental and control 
quarters. Possible interactions with time points were explored. 
 
In  study  III,  linear  random-intercept  models  were  used  to  compare  time  trend  
differences between transgenic and normal animals in milk production data, SCC, 
NAGase, bovine lactoferrin, MAA and blood SAA. Differences in the bacterial counts in 
milk, changes in milk appearance, and local and systemic signs between the groups were 
tested with generalized linear mixed models, in which a Poisson distribution was used for 
the response variables. The cow was included as a random factor. Polynomials for time in 
increasing  order  and  their  interactions  with  the  study  group were  fixed  factors  that  were  
added until significant for modelling changes in time. Overall differences in time changes 
between the groups were tested with an F-test. Due to different intervals between 
samplings, isotropic spatial exponential correlation structures were used for modelling 
serial correlations of repeated measurements within cows. Logarithmic transformation was 
used for milk SCC, NAGase activity, bLf, milk bacterial counts, and concentrations of 
MAA and serum SAA. An nlme-package (Pinheiro et al., 2006) from R 2.5.0 statistical 
software (R Development Core Team, 2006) was used for fitting linear random-intercept 
models, and generalized linear mixed models were fitted using the GLIMMIX procedure 
of SAS/STAT 9.1 (SAS Institute Inc., Cary, NC, USA). 
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In  study  IV,  statistical  analyses  were  carried  out  using  Stata  Intercooler  version  11.0  
(Stata Corporation, Texas, USA). The association between biofilm production (in TCP 
analysis) and Staphylococcus species was studied with a simple regression model. The 
absorbance  value  of  TCP was  the  outcome,  which  was  used  to  describe  the  intensity  of  
biofilm formation. The TCP absorbance values were logarithmically transformed. The 
predictor was different CNS species (categorical variable). 
  
Association of slime production with species or different origin of isolates was studied 
with separate logistic regression models. The outcome was slime production (yes/no) and 
the predictors were different CNS species or origin of isolate (reference strain/mastitis 
isolate). Association between the severity of inflammation (milk NAGase activity) and the 
results from TCP, FISH or slime production analyses was studied with separate linear 
mixed models. The outcome NAGase values were logarithmically transformed. The 
predictor was the logarithmic absorbance value of TCP, FISH (categorical variable: no 
biofilm production, weak biofilm production, clear biofilm production) or slime 
production ability. Confounding factors, parity and days in milk (DIM), were included in 
the models. The lactation stage of the cow from which the strain was isolated was a 
dichotomous variable (DIM; 0-7, n=46 and ?8, n = 68) and the parity was a categorical 
variable (parity 1, 2 and ?3). Numbers of cows in the parity groups were 54, 17 and 43, 
respectively. The cow was included in the models as a random factor. Association 
between the persistence of infection and results from TCP, FISH or slime production 
analyses were studied in three separate models (logistic regression mixed models). The 
outcome was spontaneously eliminated infection (yes=1, no=0). Predictors were TCP, 
FISH or slime production, as previously described. Confounding factors parity (parity 1, n 
= 55, parity 2, n = 26 and ?3, n = 37) and DIM were included in the models (DIM; 0-7, n = 
18  and  ?8,  n  =  100).  The  cow was  included  in  the  models  as  a  random factor.  In  these  
models data consisted of 63 isolates from one herd; this herd was included in the models 
as a fixed effect; herd W (yes/no). The model fit was assessed by visual examination of 
plots of standardized cow-level residuals, including normality and heteroscedasticity of 
the cow-level residuals (Dohoo et al., 2009). A Kappa test was used to estimate the 
agreement of phenotypic production of biofilm or slime by different methods.  
 
Descriptive data were presented as the mean values and SEM of groups. For all tests, 
p<0.05 was considered significant.  
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Results 
1 Experimental studies (I, II, III)  
1.1 Clinical findings 
All cows in studies I, II and III developed subclinical or mild clinical mastitis. In studies I 
and III cows did not have fever. In study II, nine cows of 16 had fever (t > 39.5 ºC) at one 
time point (6 or 12 h PC).  In all studies, local signs in the udder began at 12 PC and were 
mild to moderate; the highest score recorded was 2.5 in both groups in study II, and the 
mean score remained under 2. Changes in the appearance of milk were mild to moderate: 
clots and thick milk with a yellowish colour. After 36 h PC, swelling of the infected 
quarters decreased; 6 quarters of 16 became even smaller compared with the other quarters 
of the cow.  
 
Mastitis remained subclinical in the transgenic cows. None of the cows had a 
temperature over 39.0 °C, and all the local signs were scored 1, except for one cow at one 
time point when the score was 2.  
 
No changes were found in the control quarters at any time points. The hock-to-hock 
distance did not significantly change during the study period, although the individual 
measurement varied considerably. The milk ejaculation reflex affected the measurement 
so that the length between hocks was wider when taking of the milk samples was initiated.  
1.2 Elimination of infection 
All cows became infected with the bacterial species used in the inoculation Bacterial 
counts peaked in the quarters at 6 to 8 h PC (5.4–9.9 log CFU/ml) (Fig. 3). After 12 h PC, 
the bacterial counts in milk samples decreased to a constant level (3.5–5 log CFU/mL). 
 
In study I with S. chromogenes, one quarter of five remained persistent. In study II, 11 
quarters of 16, IMI remained persistent, six with S. simulans and five with S. epidermidis. 
In one cow, both infections were eliminated. The transgenic cows eliminated bacteria 
more rapidly (p<0.05) and none of the infections remained persistent (study III). 
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Figure 3. Bacterial count in infected quarters in experimental S. epidermidis (–?–), S. simulans (–
?–) and S. chromogenes (–?–, rhLf-transgenic cows –?–) intramammary infections during the 
two-week study period (n = 5 + 8 + 8 + 6). Infection persisted in 12 out of 21 quarters of the 
normal cows. The number of bacteria is expressed as a natural logarithm (ln) of CFU/ml + SEM. 
The inoculation dose was lower for S. chromogenes. 
S. epidermidis colonies from samples collected at 27–93h PC displayed haemolysis on 
blood agar. However, haemolysis was not detected after re-culturing the colonies. An API 
Staph ID 32 test yielded identical results for these suspect colonies and the inoculate 
strain. This phenomenon may be related to phase variation of bacteria or due to the effect 
of mastitic milk on the bacteria. In phase variation a part of population of bacteria changes 
phenotype because of changes in environment, for example some bacterial cells can 
change protein expression.  
1.3 Systemic innate immune response:  production of 
cytokines and SAA 
No significant changes in the concentrations of TNF-?, IL-1?, or IL-8 in serum were seen 
at any time points PC in study II.  
No differences were noted in the concentrations of SAA in the blood between animals 
infected with S. epidermidis or S. simulans (Fig. 4). In both groups, the peak concentration 
of  SAA  was  higher  than  with  S. chromogenes. No significant differences were detected 
between persistent or spontaneously eliminated infections. In the three cows with 
persistent infection, SAA did not react at all but remained at the pre-challenge level. In the 
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rhLf-transgenic group, mean SAA was lower throughout the study period and never 
exceeded 15 mg/l.  
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Figure 4. Concentration of serum amyloid A (mean ± SEM) in the blood in bovine experimental S. 
epidermidis (–?–), S. simulans (–?–) and S. chromogenes (–?–, rhLf-transgenic cows –?–) 
intramammary infection during the two-week study period shown according to the bacterial 
species (n = 5 + 8 + 8 + 6). The inoculation dose was lower for S. chromogenes. 
1.4 Indicators of inflammation in the milk 
1.4.1 SCC 
The milk SCC increased until 27 and 30 h PC, and higher counts were recorded for IMI 
induced by S. simulans (9.3 × 106 cells/  ml,  SE  0.35)  (Fig.  5),  which  tended  to  cause  a  
stronger SCC response than S. epidermidis (8.8 × 106 cells/ ml, SE 1.2) (p = 0.07 for 
AUC-analysis). No differences were detected in the SCC between persistent and 
spontaneously eliminated infections during the study period (p = 0.52). 
 
The milk SCC of the challenged quarter was slightly lower in the transgenic cows than 
in normal control cows throughout the study period, but the difference between the groups 
was not statistically significant. In the transgenic group, SCC peaked earlier, at 12 h PC, 
than in the control group. 
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Figure 5. Somatic cell count ±  SEM  in the milk in bovine experimental S. epidermidis (–?–), S. 
simulans (–?–) and S. chromogenes (–?–, rhLf-transgenic cows –?–) intramammary infection 
during the two-week study period shown according to the bacterial species (n = 5 + 8 + 8 + 6). 
The SCC is expressed as a natural logarithm of cells/ml. The inoculation dose was lower for S. 
chromogenes. 
1.4.2 Milk NAGase activity 
Milk NAGase activity peaked at 30 h PC in all experiments. No differences were noted 
between infections induced by S. simulans or S. epidermidis, or between persistent 
infections and those eliminated spontaneously (Fig. 6a). The NAGase activity of the milk 
differed between the transgenic and control cows (p < 0.001) (Fig 6b). In the transgenic 
cows, milk NAGase activity remained unchanged throughout the study period.  
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Figure 6. The milk NAGase activity ± SEM in bovine experimental mastitis during the two-week 
study period. a) S. epidermidis (–?–) (n = 8) and S. simulans (–?–) (n = 8) infections with new the 
method. b) S. chromogenes intramammary infection in normal, control cows (–?–) (n = 5) and in 
rhLf-transgenic cows (–?–) (n = 6) with the old method. 
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1.4.3 Cytokines 
In study II, increased concentrations of cytokine IL-1?, TNF-? and IL-8 were recorded in 
the milk of the experimental quarters as compared with the control quarters after the 
challenge by both bacterial species (p < 0.001).  
 
Milk IL-1? concentrations started to increase at 6 h PC, and the highest concentration 
was recorded for the S. simulans group at 12 PC. In the AUC-analysis the response of IL-
?? was stronger for S. simulans than for S. epidermidis (p = 0.03) (Fig. 7). The peak 
concentration of IL-1? in the milk at 12 h PC was lower in quarters where infection 
persisted (0.45 ng/mL, SE 0.23) than in quarters from which infections were 
spontaneously eliminated (0.61 ng/mL, SE 0.33), but the difference was not statistically 
significant (p = 0.44).  
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Figure 7. The IL-1? concentrations ± SEM in bovine experimental mastitis during the two-week 
study period S. epidermidis (–?–) (n = 8) and S. simulans (–?–) (n = 8). 
No significant difference was recorded between the CNS species (p = 0.25) for the 
production of TNF-? in the infected quarters. The concentration of TNF-? in the milk 
peaked at 21 h PC. Concentrations of TNF-? in the milk varied among individual cows; in 
four cows, hardly any response to inoculation with S. epidermidis was seen. One cow had 
a  higher  baseline  level  than  the  others  in  both  infected  and  control  quarters  at  both  
challenges, and one cow had an exceptionally strong reaction to S. simulans infection. In 
the quarters with persistent infection, TNF-? concentrations peaked later and remained 
elevated  for  longer  than  in  the  quarters  with  a  transient  infection.  No  statistically  
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significant differences in milk TNF-? concentrations between persistent and 
spontaneously eliminated infections were found in the AUC analysis.  
 
The IL-8 concentration peaked at 12 h PC (3 challenges) or 30 h PC (7 challenges), or 
at both time points (6 challenges). Infections with a peak value at 30 h PC had milder local 
signs in the udder and less changes in the milk appearance, and concentrations of 
cytokines  were  lower.  Concentrations  of  IL-8  were  higher  in  the  S. simulans group as 
compared with the S. epidermidis group and in the AUC-analysis, IL-8 response was 
stronger  (p = 0.04) (Fig. 8). The average peak IL-8 concentration in the milk of the 
quarters with a persistent infection was lower than in the quarters that had cleared the 
infection, but no significant difference was found in the AUC analysis (p = 0.27). 
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Figure 8. The milk IL-8 concentrations ± SEM in bovine experimental mastitis during the two-
week study period. a) S. epidermidis (–?–) (n = 8) and S. simulans (–?–) (n = 8).                          
b) Spontaneously eliminated (–?–) (n = 5) and persistent infections (–?–) (n = 11). 
1.4.4 Milk amyloid A and lactoferrin 
MAA concentrations in the milk before challenges were under the detection limit. MAA 
was slightly increased at 21 h after the challenge and was elevated during the next 3 days 
(Fig. 9). MAA peaked at 30–54 h PC. In low concentrations (study I, III), MAA fluctuated 
between milking times and was the highest before the morning milking. In study II, 
samples taken only at morning milking times were analysed. 
 
In study II, no difference was found between the CNS species (p = 0.15) or between 
persistent and spontaneously eliminated infections (p = 0.99) in MAA response. In study 
III,  the  concentration  of  MAA in  the  milk  during  the  experiment  was  lower  in  the  rhLf  
group (p < 0.01), but began to increase earlier (Fig 9b).  
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Figure 9. The MAA ± SEM in bovine experimental mastitis during the two-week study period. a) S. 
epidermidis (–?–) (n=8) and S. simulans (–?–) (n=8).  b) S. chromogenes intramammary infection 
with the normal cows (–?–) (n=5) and rhLf-transgenic cows (–?–) (n=6).  
In study III, the concentration of bLf in the milk peaked in both groups at 46 h PC; the 
mean concentration of bLf was 0.27 mg/ml (0.17–0.40 mg/ml) in the transgenic group and 
0.33 mg/ml (0.09–0.47 mg/ml) in the control cows. It then decreased rapidly, and no 
statistical differences were observed between the groups. The rhLf in milk remained at a 
constant level during study period. 
 
 
2 Biofilm and slime production of CNS (IV) 
2.1 TCP assay and FISH 
 
In the TCP assay, 31.3% of the mastitis isolates (n = 60/192) and 40.4% of the reference 
strains (n = 21/52) produced biofilm. The intensity of biofilm formation in TCP varied 
largely between the isolates (the mean absorbance of the mastitis isolates 0.19, SE 0.03, 
and that of the reference strains 0.23, SE 0.07).  Biofilm formation of S. epidermidis was 
stronger compared to other CNS species (p = 0.01). The mean absorbance value of S. 
epidermidis isolates was 0.63 (SE 0.31). 
 
After 72 hours incubation, 32.5% of mastitis isolates did not produce biofilm in FISH, 
30.1% had a weak, and 37.4% a clear biofilm formation. In 8 biofilm-negative mastitis 
isolates,  distinct  adhesion was seen at  18 h,  but biofilm formation was not seen at  72 h.  
The Kappa test value comparing TCP and FISH at 72 h was poor (0.22) indicating a low 
agreement between tests, but varied between species, being the lowest for S. spp. group 
(0.09) and highest for S. simulans (0.35). 
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2.2 Slime production 
With glucose supplementation, 14.1% (n = 27/192) and with lactose supplementation 
8.9% (n=17/192) of mastitis isolates produced slime in CRA analysis. Slime production of 
the reference strains was more common (48.1%; n = 25/52) with glucose than with lactose 
supplementation (21.2%; n = 11/52). The Kappa test value (0.50) between lactose and 
glucose supplementation in all isolates indicated a moderate association, but differences 
between species were seen; S. sciuri (n = 5, included in S. spp. group) did not form slime 
with lactose supplement. The slime production ability was more common in the reference 
strains than in the mastitis isolates (p = 0.02). The Kappa test value comparing TCP and 
CRA was low (0.18), indicating a low association for all isolates, but varied among 
species and was the highest for S. epidermidis (0.62). 
 
Slime production of S. chromogenes and S. simulans was less frequent than that of 
other species isolated in mastitis (OR 0.10, p = 0.03 and OR 0.17, p = 0.03, respectively). 
S. epidermidis tended to produce slime more often than other species (OR 3.88, p = 0.08).  
2.3 Adhesion genes and the bap, icaA and icaD genes 
The most commonly detected MSCRAMM gene was the eno gene, encoding laminin 
binding protein (Table 5). It was detected in 75% of mastitis isolates and in 79.6% of the 
reference strains. All S. epidermidis, S. haemolyticus and S. spp. mastitis isolates were 
positive for the eno gene. This gene was detected less frequently in S. simulans isolates 
than in isolates of other species (OR 0.009, p<0.0001). Other MSCRAMM genes were 
sporadically detected (Table 5). None of the 84 mastitis isolates studied carried bap or cna 
genes. No difference between mastitis and reference isolates in the number of 
MSCRAMM genes was found (p = 0.4). The median number of MSCRAMM genes in 
mastitis isolates was one. Two mastitis isolates, one S. simulans and S. haemolyticus, were 
different and had 7 MSCRAMM genes. The S. simulans isolate  was  FISH  and  slime  
negative and originated from subclinical mastitis. The S. haemolyticus isolate was FISH 
and slime positive and originated from clinical mastitis. Primers for icaA and icaD 
functioned well for S. aureus reference strains, but were not able to detect icaA and icaD 
genes in the known positive strain, S. epidermidis ATCC 35984 (Gill et al., 2005). For that 
reason, results for icaA and icaD genes are not presented.  
  
 
 
 
49
 
 
Table 5. MSCRAMM and bap genes detected in different CNS species isolated from bovine 
mastitis in study IV. Data are presented as positive isolates/negative isolates (n = 84). 
Gene S. 
chromogenes 
S. 
epidermidis 
S. 
haemolyticus 
S.       
simulans 
S. spp. Total (%) 
      
bap 0/22 0/10 0/18 0/24 0/10 0/84 (0) 
bbp 0/22 0/10 0/18 1/23 0/10 1/83 (1.2) 
clfA  0/22 0/10 2/16 1/23 1/9 4/80 (4.8) 
clfB  0/22 0/10 2/16 1/23 0/10 3/81 (3.6) 
cna  0/22 0/10 0/18 0/24 0/10 0/84 (0) 
ebpS 2/20 0/10 1/17 1/23 0/10 4/80 (4.8) 
eno 20/2 10/0 18/0 5/19 10/0 63/21 (75.0) 
fib 1/21 0/10 2/16 1/23 0/10 4/80 (4.8) 
fnbA 0/22 0/10 2/16 1/23 0/10 3/81 (3.6) 
fnbB 0/22 0/10 2/16 0/24 0/10 2/82 (2.4) 
 
2.4 Association between biofilm or slime production and 
inflammation in the udder quarter 
In the clinical data included in study IV, 114 milk samples from mastitic cows out of 138 
were available for milk NAGase activity determination. NAGase reflects the inflammatory 
reaction in the infected udder quarter. The mean milk NAGase activity was 10.07 4-
MU/min/µl (SE 0.83) in the milk samples analysed. Isolates with a more intense biofilm 
formation in TCP tended to cause a milder inflammation in the udder quarter (coeff. -0.09, 
p = 0.07). Milk NAGase activity was not associated with the intensity of biofilm 
production in FISH (p = 0.82) or slime producing ability in CRA (p = 0.36).  
 
CNS infections caused a stronger inflammation near calving. NAGase activity in the 
milk in CNS mastitis soon after calving was higher than in later lactation (p = 0.03); the 
difference was most clearly seen in mastitis caused by S. simulans (interaction with DIM). 
2.5 Association of persistence of infection with biofilm or 
slime production 
A total of 63 mastitis isolates were from persistent infections and 55 isolates were from 
spontaneously eliminated infections. Biofilm formation in TCP (n = 118) or in FISH (n = 
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90) was not associated with the persistence of infection (p = 0.40 and p = 0.76). Slime 
production was more common in isolates from IMIs remaining persistent (OR for 
elimination of infection was 0.02, p = 0.05) (Table 6). Among isolates from persistent 
infections, 8 (12%) produced slime. 
Table 6. Association between the ability of CNS isolates from bovine mastitis to produce slime and 
persistence of intramammary infection caused by these isolates; the final logistic regression mixed 
model shown. Data derived from 63 isolates from persistent infection and 55 isolates from 
eliminated infection. OR is the odds ratio for elimination of infection. 
Predictor OR  SE p-value  95% CI 
Slime production  0.01 0.03 0.05 0–1.01 
Parity 1 1.00    
Parity 2 0.80 0.71 0.80 0.14–4.62 
Parity 3 18.06 26.58 0.05 1.01–323.26 
Parity ?4 1.34 1.35 0.77 0.19–9.56 
DIM ?8 days 0.10 0.12 0.06 0.01–1.09 
Herd 58 8.09 8.73 0.05 0.97–67.07 
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Discussion 
Pathogenicity of the CNS in mammary glands 
CNS have traditionally been considered to be minor pathogens in bovine mastitis as 
compared with the major pathogens such as Staphylococcus aureus, streptococci, and 
coliforms.  The  main  reason  for  this  is  that  mastitis  caused  by  CNS  is  very  mild  and  
usually remains subclinical (Taponen and Pyörälä, 2009). This kind of classification is 
artificial and mainly takes into account only the degree of inflammation. In addition, 
mastitis is a dynamic process where a clinical phase can become subclinical. Furthermore, 
in chronic, subclinical mastitis, clinical flare-ups are possible. Mastitis is a complex 
disease and the intensity of inflammation caused by different bacterial species varies. 
 
Bacteria have to alarm the host response to be pathogenic (Jones and Hunt, 1983). 
CNS  species  meet  this  criterion  as  they  are  able  to  trigger  the  immune  response  of  the  
cow. Intramammary infections caused by CNS raise milk SCC in the bovine udder, which 
is the most well known phase of IMI (Taponen et al., 2007; Supré et al., 2011) 
Concentrations of APPs (Wenz et al., 2010; Pyörälä et al., 2011) and cytokines in the milk 
increase during CNS infections (Wenz et al., 2010) (study II). Colonization by bacteria 
and their multiplication at the infection site are essential steps for a disease to develop. To 
establish the infection after invasion, bacteria need to avoid the host defence mechanisms 
(Quinn et al., 2002). Pathogen-related determinants of bacteria are route of entry, 
virulence characteristics, their susceptibility to the host defence, stability in the 
environment, infective dose and tissue tropism (Quinn et al., 2002). Virulence of CNS is 
rather low compared with most other mastitis-causing bacteria. However, a wide variety of 
virulence genes and characteristics have been detected for CNS isolates from bovine IMI, 
even though the most potent ones are rare (Kuroishi et al., 2003; Oliveira et al., 2006; Park 
et al., 2011b) (study IV).  
 
Many  CNS  species  are  present  in  the  environment  and  on  the  skin  of  the  cow  (De  
Vliegher et al., 2003; Taponen et al., 2008; Piessens et al., 2011). The route of entry into 
the udder quarter is via the teat canal, but the infective dose and the course of a natural 
infection  are  unknown  to  date.  Bovine  CNS  infections  are  typically  localized  in  the  
mammary gland, but in other animals and humans, CNS infect various tissues and targets. 
In  conclusion,  for  the  dairy  cow  CNS  are  always  present,  being  ready  to  invade  the  
mammary gland if the host defence fails. CNS accumulate in the mammary gland and 
often cause persistent infections, which represents a key problem in the herds with CNS 
mastitis. 
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Experimental CNS mastitis model 
The studies included in this thesis describe experimental mastitis models for different 
CNS species. The challenge dose used was high as compared with doses used to induce S. 
aureus or E. coli mastitis  (Schukken et  al.,  1999;  Riollet  et  al.,  2000;  Bannerman et  al.,  
2004b; Hyvönen et al., 2006b). In a study by Holmberg (1973), several CNS strains were 
used in challenges with high and low doses (1.4 x108–5.1 x108 CFU and 2.8 x103–27.0 
x103 CFU,  respectively).  In  the  high  dose  group,  all  6  cows  had  short-term  clinical  
mastitis. With the low dose (20 CNS strains and 26 cows), most cows developed 
persistent, subclinical mastitis. Unfortunately, the identification methods, taxonomy and 
nomenclature  used  for  CNS  were  different  at  that  time,  and  all  26  CNS  isolates  were  
classified as S. epidermidis. Further comparisons with that early study are thus not 
possible. In our experiments, systemic signs were mild or did not appear at all, and local 
signs seen in the infected udder quarters were mild to moderate in all cows. The high 
inoculum dose used here may have caused a rapid immune response that enhanced the 
elimination of bacteria. However, in the preliminary limited challenge tests we failed to 
infect cows with two lower doses of CNS. A high dose may be required to induce clinical 
CNS mastitis experimentally and the intensity of inflammation is associated with the 
inoculation dose. 
The innate immune response in CNS intramammary infection  
Experimental infection with three CNS, S. chromogenes, S. epidermidis and S. simulans, 
induced clinical mastitis with short-term mild or moderate signs. The local immune 
response was manifested as increased concentrations of cytokines, APPs and indicators of 
inflammation in the milk. Systemic signs, if they developed at all, were mild or moderate; 
fever in some cows was observed only at one time point PC.  
 
The S. chromogenes strain  originated  from  clinical  mastitis,  but  even  though  the  S. 
simulans and S. epidermidis strains were from subclinical mastitis, all caused short-term 
clinical signs. This may be related to the experimental model with a relatively high 
inoculum dose; under field conditions CNS infections probably progress more slowly and 
mostly without clinical signs. However, spontaneous CNS infections can result in clinical 
mastitis (Olde Riekerink et al., 2008; Tenhagen et al., 2009; Wenz et al., 2010). As stated 
earlier, mastitis represents a dynamic process; clinical mastitis typically turns to 
subclinical mastitis during the course of the disease (Pyörälä and Mattila, 1987; Grönlund 
et al., 2003). Clinical signs of a short duration may be missed under the farm conditions. S. 
simulans infection resulted in a slightly stronger innate immune response than S. 
epidermidis,  which  could  indicate  that  some CNS species  are  more  virulent  than  others.  
However, virulence characteristics of typical mastitis-causing S. simulans and S. 
epidermidis are not known. 
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SCC of the infected quarter can be relatively low in CNS mastitis compared with 
mastitis caused by major pathogens (Djabri et al., 2002). In our studies with an 
experimental CNS mastitis model, milk SCC of the infected quarters increased to a high 
level. The milk SCC decreased to 230 000 cells/ml two weeks after challenge, with no 
difference between spontaneously eliminated and persistent infections. Milk SCC did not 
increase again in the quarters with persistent infection at the time when the bacterial 
growth started to increase. This could indicate that the reactivated infection did not trigger 
a strong immune response.  
 
NAGase is a lysosomal enzyme that reflects damage in the udder tissue due to 
inflammation. In our experimental models, milk NAGase activity increased only 
moderately, indicating the mild nature of CNS IMI. In more severe infections, such as 
mastitis due to E. coli, NAGase activity in the milk can be 9–10 times as high as in the 
normal milk, indicating considerable tissue damage (Hyvönen et al., 2006b). In a recent 
field study by Pyörälä et al. (2011), the median NAGase activity in the milk in 
spontaneous CNS mastitis was 6.9 pmol 4-MU/min/µl (25-75%: 2.1-16.7), which is at a 
similar level as reported here in study II. 
 
CNS infection induced an IL-1?, IL-8, and TNF-? response in the mammary gland. 
Concentrations of IL-1? in the milk were comparable with those recorded for 
experimental IMIs induced by S. aureus and E. coli (Riollet et al., 2000; Bannerman et al., 
2004b). However, the peak levels were reached earlier, possibly due to the large 
inoculation dose used in our studies. In a field study by Wenz et al. (2010) of spontaneous 
mastitis, IL-1? concentrations in milk from cases of CNS mastitis determined at the time 
of diagnosis were approximately half of those in milk from streptococcal mastitis. 
Comparison between results of a field study and our experimental data is however 
difficult, as in the field data only one time point was included, without knowledge about 
the exact phase of the spontaneously occurring IMIs.  
 
In study II, the IL-8 responses of the cows differed between challenges. The responses 
could be divided into early or delayed responses, or combined responses including two 
peaks. No association was established between the IL-8 concentrations and CNS species, 
persistence of IMI or the clinical response of individual cows. The first peak in the IL-8 
concentration was recorded at the same time, around 12 h PC, as seen in earlier 
experimental challenge studies using E. coli or other Gram-negative bacteria (Bannerman 
et al., 2004b; Bannerman, 2009). In experimental IMI induced by a Gram-positive 
bacterium, Streptococcus uberis, a delayed IL-8 response at 30 h PC was reported 
(Bannerman et al., 2004a). In contrast, no IL-8 response was recorded in two studies on 
experimentally induced S. aureus mastitis (Riollet et al., 2000; Bannerman et al., 2004b), 
but in a third study, IL-8 transcripts were detected in the milk (Lee et al., 2006). In those 
studies, the inoculation doses of S. aureus were much lower than in our study, from 50 to 
100  CFUs.  Results  from  different  experiments  are  difficult  to  compare  because  of  
differences in inoculation doses, bacterial species and strains, and analytical methods. 
Variation in the responses between individual cows is well known and further complicates 
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the comparison. In our study, milk samples were frozen before centrifugation. Thus, both 
extracellular cytokines and those released from ruptured cells contributed to the 
determined concentrations. If the milk sample is centrifuged immediately after sampling, 
whey contains only extracellular cytokines. In our data, TNF-? concentrations in the milk 
varied among individual cows, which makes interpretation of the results difficult. One 
cow had a high basic level in all quarters, and another cow was over-reacting, without any 
reason or visible clinical signs. 
 
Acute phase proteins are involved in the early state response of the host to infections. 
Stimulated by pro-inflammatory cytokines, SAA is excreted from the liver, but also 
produced locally in the mammary epithelial cells (Jacobsen et al., 2005a; Weber et al., 
2006). Concentrations of cytokines IL-1?, TNF-? and IL-8 in the systemic circulation 
were determined in study II, with no changes as compared with the pre-challenge 
concentrations. Despite that a systemic acute phase response was induced because 
increased concentrations of SAA in the circulation were recorded. In three cows, SAA 
remained  at  the  basic  level  over  the  whole  experimental  period,  and  they  all  developed  
persistent mastitis. Mean SAA concentrations between spontaneously eliminated and 
persistent infections in study II did not differ however. It may be possible that lack of 
systemic response could contribute to the result of infection. 
 
APPs in milk reflect the inflammation and severity of inflammation in the quarter. 
MAA, also called SAA3, has an antimicrobial effect, at least regarding E. coli, Str. uberis 
and Pseudomonas aeruginosa (Molenaar et al., 2009). It  is  suggested to represent a new 
diagnostic tool for mastitis (Grönlund et al., 2005; Pyörälä et al., 2011). In study I, MAA 
was affected by milking times, and was at its highest before the morning milking, 
probably reflecting the longer interval between evening and morning milking. The 
variation in concentrations of MAA may have been seen in this mild infection model due 
to the relatively low rise in MAA. It was not reported in a more severe experimental 
mastitis model with E. coli (Jacobsen et  al.,  2005b; Hyvönen et  al.,  2006b).  The time of 
sampling in relation to milking should perhaps be taken into account when interpreting 
MAA concentrations in mild IMI models. In study II, only morning milking samples were 
analysed.  
 
At the end of the follow-up periods in studies II and III, concentrations of MAA 
decreased to the basic level, even if the infection persisted. The same was noted for milk 
NAGase activity, which also returned to a pre-challenge level even in the quarters where 
infection persisted (study II). This finding is contrary to numerous earlier experimental 
and field studies on major pathogens, where concentrations of APPs and SCC in the milk 
remained elevated if infection was not eliminated (Pyörälä and Pyörälä, 1997; Grönlund et 
al., 2003; Bannerman et al., 2004a; Bannerman et al., 2004b). It is possible that 
concentrations of these markers start to increase later, along with the persisting infection. 
The study period here was only two weeks in duration. However, if this finding also holds 
for  spontaneous  CNS  mastitis,  it  could  have  clinical  relevance.  It  is  already  known  that  
many CNS IMIs in herds can have a reasonably normal SCC when sampling is done at a 
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single time point. Milk indicators of inflammation are commonly used to monitor cure 
from IMIs caused by all bacteria, CNS included (Pyörälä, 2003). 
Lactoferrin as a part of the innate immune response 
Genetic manipulation could be one means to prevent disease in animals, but it is also a 
tool for research. Lactoferrin is an iron-binding glycoprotein secreted by glandular 
epithelial cells and is found in the secondary granules of PMN. Lf has well described 
bacteriocidal, bacteriostatic immunomodulatory and anti-inflammatory effects (Nuijens et 
al., 1996; Nibbering et al., 2001; Brock, 2002; Kawai et al., 2007). The concentration of 
Lf in the bovine milk increases in mastitis. 
 
The results from our study using rhLf-transgenic cows (study II) for investigating the 
effects of high inherent Lf concentrations and prevention of CNS mastitis were not 
unequivocal. Expression of rhLf in the milk in the transgenic cows did not prevent 
infection with S. chromogenes, and all challenged quarters became infected. However, 
rhLf-transgenic cows showed a significantly milder inflammatory response than did the 
control cows, and they eliminated the infection significantly faster. In an experimental 
mastitis study with these transgenic animals and E. coli infection the protective effect was 
weaker (Hyvönen et al., 2006b). Strong conclusions cannot be made regarding this 
experiment, which included relatively few cows, challenged with a single dose of one 
CNS strain. 
 
In milk of normal dairy cows, the concentration of Lf is so low that its antimicrobial 
effect in defence of the mammary gland is probably minor. During mastitis, the anti-
inflammatory  activity  of  Lf  may  play  some  role  (Rainard  and  Riollet,  2006).  In  rhLf-
transgenic cows, the inherent high Lf concentration in the milk could limit infection at an 
early stage, and the inflammation would also remain mild and brief. Lactoferrin down-
regulates the secretion of proinflammatory cytokines, which stimulate SAA and MAA 
secretion (Appelmelk et al., 1994), but the immunomodulatory properties of rhLf in the 
bovine udder are unknown.  
 
The concentration of bLf in the milk increased after challenge similarly in both groups, 
and the rhLf present in the milk of the transgenic cows did not interfere with this response. 
In clinical mastitis, bLf concentrations in the milk can be over 10 times as high as those in 
the milk of healthy cows, and in cases of chronic mastitis, about 7 times as high (Komine 
et al., 2005). In study II, the maximum concentrations of bLf in the milk were only about 
twice as high as those observed prior to the challenge, indicating the mild nature of CNS 
mastitis. Transgenic cows showed no significant changes in milk NAGase activities, 
which may reflect the minor damage to the epithelial cells of the challenged quarters. Lf is 
known to inhibit the secretion of some bacterial exoproteins, which cause tissue damage 
(Diarra et al., 2002). SCC in the milk showed no differences between the groups, but 
increased SCC apparently had no impact on milk NAGase activity in this model. The main 
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part of NAGase is released from epithelial cells to milk, but somatic cells also contribute 
(Kitchen et al., 1978). Milder tissue damage and local inflammatory response in transgenic 
cows was also supported by lower MAA response. 
 
In an earlier study by Wall et al. (2005), transgenic cows expressing lysostaphin in 
their milk were bred. Lysostaphin is a metalloenzyme, which affects the cell wall of 
staphylococci; it is staphylocidal (Kumar, 2008). Lysostaphin-transgenic cows were 
resistant to an experimental S. aureus intramammary challenge. As a candidate molecule 
for transgenesis, Lf could be of greater potential due to its broader antibacterial spectrum, 
and additional immunomodulatory effects compared with lysostaphin. However, the 
susceptibility of bacteria to Lf differs among species and strains (Kutila et al., 2003b; 
Chaneton et al., 2008). The sensitivity to Lf in vitro varies among CNS isolates (Hyvönen 
et al., 2009).  
 
Gene manipulation however is not a solution to mastitis in commercial dairy farms. Lf 
alone or in combination with antimicrobials could be used in the treatment of bovine 
mastitis (Kai et al., 2002b; Kutila et al., 2004; Komine et al., 2006; Petitclerc et al., 2007; 
Lacasse et al., 2008). Modification of Lf by hydrolysation to lactoferrin hydrolysate has 
been demonstrated to enhance its efficacy (Kawai et al., 2003; Kawai et al., 2007). The 
combination of Lf and benzylpenicillin showed efficacy against penicillin-sensitive and 
even against penicillin-resistant strains of S. aureus in vitro and in vivo (Diarra et al., 
2002; Petitclerc et al., 2007). 
The effect of bacterial factors in intramammary infections: biofilm 
and slime production 
 
Many different bacterial species can produce biofilm. Biofilms can play a role in bacterial 
contamination related to food safety and in infections associated with implants and devices 
in human medicine. Biofilm formation is probably important in maintaining chronic 
infections, for instance in dental caries and biliary tract infections (Costerton et al., 1999). 
An association between mastitis and biofilm formation of mastitis-causing bacteria has 
been proposed, but to date scientific evidence is lacking (Melchior et al., 2006). In study 
IV, one-third of CNS isolates from mastitis produced biofilm in TCP and in FISH 
analysis. Phenotypic biofilm production was not associated with the intensity of 
inflammation of infections, except for a tendency towards milder inflammation in IMI 
caused by isolates with more intense biofilm production in TCP. In an earlier study using 
an experimental ovine S. aureus mastitis model (Baselga et al., 1993), slime produced by 
the challenge strain was connected with a decreased clinical severity of the disease and 
with an increased capacity of bacteria to colonise.  
 
 Lf inhibits biofilm formation of staphylococci (Leitch and Willcox, 1999b). To form 
biofilm, some bacteria require higher levels of iron than for vegetative growth (Weinberg, 
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2004). The anti-biofilm effect of Lf can be related to its well known ability to sequester 
iron (Nuijens et al., 1996). This would support the elimination of bacteria by the host, or 
make the invading bacteria more susceptible to antimicrobial treatment (Leitch and 
Willcox, 1999b). Absent or weak biofilm production due to Lf in the milk could be a one 
explanation for our results concerning lack of association between biofilm production of 
the bacterial strains and clinical characteristics of mastitis. 
 
Adhesion to a living or devitalized surface is performed with specific molecular 
binding ligaments termed adhesins (Dunne, 2002). Staphylococcal MSCRAMM genes are 
a group of 9 genes connected to adhesion of host tissues via extracellular matrix 
components (Patti et al., 1994). In this dissertation, the most commonly detected adhesion 
gene among mastitis-causing CNS strains was eno, which encodes laminin-binding 
protein. Laminin is a component of the basement membrane between the epithelial cells 
and connective tissue in the mammary gland. This gene has also been found in CNS 
originating from filtered air and from infections in dogs and swine (Seo et al., 2008). In 
the present study, S. simulans harboured the eno gene  more  seldom  than  other  species,  
which could indicate that this species uses an alternative mechanism for tissue adhesion. 
Another explanation is simply that the gene was not detected using our primers due to a 
different sequence in the target area in this species. MSCRAMM genes are more frequent 
in S. aureus: isolates originating from rabbits had 7 MSCRAMM genes (median) 
(Vancraeynest et al., 2004) and isolates from humans had 6 genes (Tristan et al., 2003). 
The absence of these genes in our CNS isolates, except for the eno gene, is consistent with 
the  results  of  Seo  et  al.  (2008),  who  detected  MSCRAMM  genes  in  CNS  from  other  
sources, but not from mastitis isolates. 
 
Definitions for biofilm-positive and slime-positive isolates differ among studies. The 
use of genotypic methods does not facilitate the interpretation. In vitro phenotypic 
methods are sensitive to environmental conditions. Genotypic methods would require 
precise knowledge of all the targets in different species. However, not all biofilm-related 
genes  or  characteristics  of  different  gene  combinations  are  known (Stevens  et  al.,  2009;  
Los et al., 2010). When detecting genes from different species, as in the CNS group with 
identical primers, conserved sequences are required. This uncertainty decreases the 
sensitivity of the gene detection of different CNS species. In sequence comparison of the 
bap locus for 5 different CNS species, however, the degree of similarity was high and the 
bap gene was detected in the species with the same primers as used in study IV (Tormo et 
al., 2005). 
Persistence of intramammary infection 
Host response and the characteristics of invading bacteria both contribute to the 
elimination of IMI. Besides the cow factors (parity, lactation stage, the immune response) 
also  herd  factors  (nutrition,  management)  play  a  role.  Persistence  seems  to  be  a  typical  
phenomenon in CNS IMI not treated with antibiotics, although the spontaneous 
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elimination rate of CNS infections is generally high as compared with some other Gram-
positive species. About 50% of CNS infections are eliminated spontaneously (Taponen et 
al., 2006; Thorberg et al., 2009; Supré et al., 2011), in contrast to 0-6% in S. aureus IMI 
(Oliver et al., 2004; Deluyker et al., 2005) and approximately 30% in Str. uberis IMI 
(Zadoks et al., 2003; Deluyker et al., 2005). In study IV, 53% of isolates from our 
previous field studies (Taponen et al., 2006; Taponen et al., 2007) were isolated from 
persistent infections. Including the experimental studies without transgenic cows, the 
infection was eliminated from 9 quarters out of 21, i.e. the spontaneous elimination rate in 
experimental CNS infections was 43%. All three species studied could cause persistent 
infection. Some studies have found differences between species. S. chromogenes has been 
isolated from persistent infections more than other CNS species, but S. epidermidis and S. 
simulans have also been detected in persistent infections (Thorberg et al., 2009; Supré et 
al., 2011). 
 
Incidence of CNS IMIs has apparently increased in many regions, and proportion of 
infected cows can be very high in herds with CNS mastitis problems. Problems with CNS 
infections have not been resolved using traditional mastitis control measures, but such 
infections appear to increase in well-managed dairy farms. Transient CNS infections have 
a minor effect on bulk milk SCC, but persistent infections may contribute more. 
Consequently, the persistence of CNS infection merits more research. If some factors 
affecting persistent infections were found and prevalence of persistent infections 
decreased, this would have an impact on the economics of the farm.  
 
In study II, the innate immune response was stronger in spontaneously eliminated 
infections,  but  a  statistical  difference  was  not  established.  The  power  of  the  statistical  
analysis was weaker than in comparison of species because the crossover model could not 
be used. The number of cases in each study group was difficult to control because it was 
not possible to determine the group size beforehand when comparing persistent and 
spontaneously eliminated infections.  
 
The concentration of TNF-? in the milk, in study III, was the only parameter at the end 
of the study period whose concentration remained at a higher level in the milk in the 
quarters with persistent infections. One explanation could be that described in an in vitro 
study by Wilsson et al. (2008). They found that macrophages phagocytosing apoptotic 
neutrophils containing S. epidermidis released TNF-? and IL-6 more than spontaneously 
apoptotic neutrophils. S. epidermidis also delayed apoptosis of neutrophils (Wilsson et al., 
2008), which is connected to chronic infections and sepsis (Simon, 2003). 
 
In  persistent  CNS  infections  in  our  studies,  bacterial  counts  first  decreased  after  the  
acute phase and then increased to a rather constant level. In some cows infection was 
activated and bacterial counts increased to a quite high level. In study I, Lf concentration 
in the milk responded with reactivation of the infection. In study II, no such response was 
detected for any of the indicators of inflammation during the experimental period of two 
weeks.  
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Biofilm and slime production of the CNS strain would be a tempting explanation for 
the persistency of infection. In study IV, phenotypic biofilm production was not, however, 
associated with the persistence of infection. In previous studies on human infections 
caused by S. epidermidis, production of biofilm was connected with persistent infections, 
in particular those associated with prosthesis and devices (Piette and Verschraegen, 2009). 
In our study, slime production was associated with persistent IMIs. Biofilm and slime 
production were more common in S. epidermidis than  in  other  CNS  species.  Slime  
production may enhance the occurrence of persistent infections caused by S. epidermidis, 
this being one possible explanation for the high prevalence of S. epidermidis IMIs seen in 
some herds (Thorberg et al., 2009).  
 
The most common mastitis species (S. chromogenes and S. simulans) produced slime 
less frequently than other species. In general, mastitis isolates also produced slime less 
frequently than the reference strains used. The reference strains used were mainly isolated 
from human skin or infections, skin of various animals or food supplies. Characteristics of 
bovine-associated staphylococci can have host and tissue specificity, and differ from other 
CNS. In a study concerning S. aureus, recovery from mastitis caused by bovine-associated 
strains differed from strains of non-bovine-associated sequence types (van den Borne et 
al., 2010a). Factors other than slime-forming ability must contribute to the frequently 
persistent infections in CNS mastitis. 
 
  
 
 
 
60
Conclusions 
? Experimentally induced intramammary infections with S. chromogenes, S. 
simulans and S. epidermidis resulted in mild clinical mastitis, and cytokine and 
APP responses in the milk of the challenged quarters. A systemic serum 
amyloid A response was also detected, but concentrations of cytokines did not 
increase in serum.  
 
? S. simulans caused a slightly stronger innate immune response than S. 
epidermidis.  
 
? Spontaneously eliminated infections tended to have stronger immune 
responses, although the differences were not statistically significant. 
Concentrations of the indicators of inflammation in the milk decreased at the 
same  rate  in  spontaneously  eliminated  and  persistent  infections  to  the  end  of  
the study period, except for the concentration of TNF-?, which remained 
elevated in persistent infections. 
 
? Transgenic cows expressing rhLf in their milk were more resistant to 
experimental CNS mastitis than control cows: they eliminated S. chromogenes 
from the mammary gland faster and had milder clinical and local inflammatory 
responses. 
 
? One third of the CNS mastitis isolates produced biofilm in vitro. Biofilm 
production was not associated with CNS isolates with a stronger inflammatory 
reaction or with persistence of infection. 
 
? 9% of the CNS mastitis isolates produced slime. Slime production was 
associated with persistence of infection. S. epidermidis produced more slime 
than other CNS species, which might promote predominance of S. epidermidis 
over other CNS species in some herds.   
 
? Biofilm or  slime production  was  not  associated  with  CNS species  commonly  
isolated from mastitic milk, except S. epidermidis. It is unlikely that they would 
contribute to overall persistence of CNS intramammary infection. 
 
? The eno gene was the only MSCRAMM adhesion gene commonly detected in 
CNS isolated from mastitic milk. Other MSCRAMM genes were detected only 
sporadically. 
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Future aspects 
With improved species-level diagnostics and increasingly more knowledge becoming 
available on the virulence of CNS species, control measures could be targeted at the more 
harmful representatives of the group. Little is also known about putative virulence factors 
affecting persistent intramammary infections. Some evidence that transmission between 
cows can exist is available, but possible transmission routes of the common CNS mastitis 
species  in  the  herd  remain  unknown.  Current  strategies  for  control  of  CNS  mastitis  are  
relatively inefficient, which indicates that there exist critical points to prevent CNS 
intramammary infections. 
 
More epidemiological studies centred on risk factors from high and low prevalence 
CNS IMI herds are needed. The distribution of species varies among herds but the reasons 
for it are unknown and could be relevant. The precise localisation of the infection caused 
by CNS in the mammary gland is not yet known. Many questions remain concerning the 
possible presence of bacteria inside the epithelial cells and intracellular survival, as well as 
differences among CNS species in this respect.  
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